Benefytt (BFYT) 10-Q 14 May 15 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2015	8-May-15
Entity Information [Line Items]
Document Type	10-Q
Amendment Flag	FALSE
Document Period End Date	31-Mar-15
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Trading Symbol	HIIQ
Entity Registrant Name	Health Insurance Innovations, Inc.
Entity Central Index Key	1561387
Current Fiscal Year End Date	-19
Entity Filer Category	Smaller Reporting Company
Class A common stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		7,681,096
Class B common stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		6,841,667

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$10,517,000	$16,154,000
Cash held on behalf of others	4,756,000	5,744,000
Short-term investments		461,000
Accounts receivable, net, prepaid expenses and other current assets	1,887,000	2,332,000
Advanced commissions	8,022,000	5,973,000
Note receivable	1,014,000
Income taxes receivable	115,000	12,000
Total current assets	26,311,000	30,676,000
Property and equipment, net	996,000	526,000
Goodwill	41,076,000	41,076,000
Intangible assets, net	12,829,000	13,565,000
Other assets	1,204,000	329,000
Total assets	82,416,000	86,172,000
Current liabilities:
Accounts payable and accrued expenses	9,330,000	11,397,000
Current portion of contingent acquisition consideration	2,254,000	2,647,000
Deferred revenue	150,000	64,000
Deferred tax liability	13,000	13,000
Due to member	229,000	229,000
Other current liabilities	192,000	189,000
Total current liabilities	12,168,000	14,539,000
Contingent acquisition consideration	1,205,000	1,753,000
Deferred tax liability	1,896,000	2,287,000
Due to member	512,000	387,000
Other liabilities	442,000	494,000
Total liabilities	16,223,000	19,460,000
Commitments and contingencies
Stockholders’ equity:
Preferred stock (par value $0.001 per share, 5,000,000 shares authorized; no shares issued and outstanding)
Additional paid-in capital	44,637,000	42,647,000
Treasury stock, at cost (269,729 and 47,144 shares, respectively)	-2,793,000	-347,000
Accumulated deficit	-3,641,000	-3,694,000
Total Health Insurance Innovations, Inc. stockholders’ equity	38,218,000	38,621,000
Noncontrolling interests	27,975,000	28,091,000
Total stockholders’ equity	66,193,000	66,712,000
Total liabilities and stockholders' equity	82,416,000	86,172,000
Class A common stock
Stockholders’ equity:
Common stock	8,000	8,000
Total stockholders’ equity	8,000	8,000
Class B common stock
Stockholders’ equity:
Common stock	7,000	7,000
Total stockholders’ equity	$7,000	$7,000

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Treasury stock, shares	269,729	47,144
Class A common stock
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	7,910,085	7,900,085
Common stock, shares outstanding	7,640,356	7,852,941
Class B common stock
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	6,841,667	6,841,667
Common stock, shares outstanding	6,841,667	6,841,667

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Income Statement [Abstract]
Revenues (premium equivalents of $38,281 and $30,951 for the three months ended March 31, 2015 and 2014, respectively)	$22,541	$17,927
Operating expenses:
Third-party commissions	10,834	8,882
Credit card and ACH fees	485	359
Selling, general and administrative	11,164	7,914
Depreciation and amortization	784	405
Total operating expenses	23,267	17,560
(Loss) income from operations	-726	367
Other (income) expense:
Interest income	-7	-15
Fair value adjustment to contingent acquisition consideration	-491	722
Other income	-148	-60
Net income (loss) before income taxes	-80	-280
Benefit for income taxes	-336	-32
Net income (loss)	256	-248
Net income (loss) attributable to noncontrolling interests	203	-174
Net income (loss) attributable to Health Insurance Innovations, Inc.	$53	($74)
Net income (loss) per share attributable to Health Insurance Innovations, Inc.
Basic	$0.01	($0.01)
Diluted	$0.01	($0.01)
Weighted average Class A shares outstanding
Basic	7,515,053	5,025,669
Diluted	7,714,339	5,025,669

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements Of Operations (Parenthetical) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Income Statement [Abstract]
Premium equivalent amount	$38,281	$30,951

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Stockholders' Equity (USD $)	Total	Additional Paid-in Capital	Treasury Stock	Retained Earnings	Noncontrolling Interests	Private Placement	Private Placement	Class A common stock	Class A common stock	Class B common stock
In Thousands, except Share data							Additional Paid-in Capital		Private Placement
Beginning balance at Dec. 31, 2013	$57,777	$28,787	($1,563)	($3,355)	$33,894			$5		$9
Beginning balance, shares at Dec. 31, 2013			129,881					5,179,713		8,566,667
Net (loss) income	423			-339	762
Common stock issued as acquisition consideration	6,734	6,733						1
Common stock issued as acquisition consideration, shares								815,991
Issuance of Class A common stock in private offering						20,959	20,957		2
Issuance of Class A common stock in private offering, shares									1,725,000
Purchase of Series B Membership interest and exchange and cancellation of Class B common stock	-20,925	-14,622			-6,301					-2
Purchase of Series B Membership interests and exchange and cancellation of Class B common stock, shares										-1,725,000
Repurchases of Class A common stock	-304		-304
Repurchases of Class A common stock, shares			43,318					-43,318
Issuances of Class A common stock under equity compensation plans, shares								49,500
Class A common stock withheld in treasury from restricted share vesting	-142		-142
Class A common stock withheld in treasury from restricted share vesting, shares			12,403					-12,403
Forfeitures of restricted stock held in treasury		131	-131
Forfeitures of restricted stock held in treasury, shares			11,542					-11,542
Issuances of restricted shares from treasury		-1,793	1,793
Issuances of restricted shares from treasury, shares			-150,000					150,000
Stock compensation expense	2,454	2,454
Distributions	-264				-264
Ending balance at Dec. 31, 2014	66,712	42,647	-347	-3,694	28,091			8		7
Ending balance, shares at Dec. 31, 2014			47,144					7,852,941		6,841,667
Net (loss) income	256			53	203
Repurchases of Class A common stock	-482		-482
Repurchases of Class A common stock, shares	67,152		67,152					-67,152
Issuances of Class A common stock under equity compensation plans, shares								10,000
Class A common stock withheld in treasury from restricted share vesting	-35		-35
Class A common stock withheld in treasury from restricted share vesting, shares			5,433					-5,433
Forfeitures of restricted stock held in treasury		1,929	-1,929
Forfeitures of restricted stock held in treasury, shares			150,000					-150,000
Stock compensation expense	61	61
Distributions	-319				-319
Ending balance at Mar. 31, 2015	$66,193	$44,637	($2,793)	($3,641)	$27,975			$8		$7
Ending balance, shares at Mar. 31, 2015			269,729					7,640,356		6,841,667

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements of Cash Flows (unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Operating activities:
Net income (loss)	$256	($248)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Stock-based compensation	61	405
Depreciation and amortization	784	405
Fair value adjustment to contingent acquisition consideration	-491	722
Gain on sale of available-for-sale securities		-20
Deferred income taxes	-391
Changes in operating assets and liabilities:
Decrease in cash held on behalf of others	988	690
Decrease (increase) in accounts receivable, prepaid expenses and other assets	635	-1,003
Increase in income taxes receivable	-103	-35
Increase in advanced commissions	-2,924	-2,264
Decrease in accounts payable, accrued expenses and other liabilities	-2,187	-133
Increase in due to related parties pursuant to tax receivable agreement	125
Increase (decrease) in deferred revenue	86	-365
Net cash used in operating activities	-3,350	-1,846
Investing activities:
Proceeds from sale of available-for sale securities	461	33,020
Capitalized website development costs	-373
Issuance of note receivable	-1,014
Acquisition of available-for-sale securities		-18,000
Proceeds from maturities of held-to-maturity securities		3,223
Payments for deposits		-500
Purchases of property and equipment	-26	-121
Net cash (used in) provided by investing activities	-952	17,622
Financing activities:
Distributions to member	-319	-921
Payment of contingent acquisition consideration	-450	-450
Purchases of treasury stock	-482
Withholdings of restricted stock awards held in treasury	-35	-117
Payments for noncompete obligation	-49	-44
Net cash used in financing activities	-1,335	-1,532
Net (decrease) increase in cash and cash equivalents	-5,637	14,244
Cash and cash equivalents at beginning of period	16,154	18,429
Cash and cash equivalents at end of period	10,517	32,673
Supplemental Disclosure of non-cash investing activities:
Capitalized software development costs included in accounts payable	120
Variable interest entity
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Gain on deconsolidation of variable interest entity	($189)

Organization_Basis_of_Presenta

Organization, Basis of Presentation and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2015
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Organization, Basis of Presentation and Summary of Significant Accounting Policies	1. Organization, Basis of Presentation and Summary of Significant Accounting Policies
	In this quarterly report, unless the context suggests otherwise, references to the “Company,” “we,” “us” and “our” refer \ to Health Insurance Innovations, Inc. and its consolidated subsidiaries. The terms “HII”, “HPIH”, and “ICE” refer to the stand-alone entities Health Insurance Innovations, Inc., Health Plan Intermediaries Holdings, LLC, and Insurance Center for Excellence, LLC, respectively. The term “Secured” refers to Sunrise Health Plans, LLC, Sunrise Group Marketing LLC, and Secured Software Solutions LLC, collectively. The term “SIL” refers to Simple Insurance Leads LLC, a partially-owned venture we and a third party formed in June 2013; we sold our interest in SIL to our joint venture partner on March 23, 2015. The term “HP” refers to HealthPocket, Inc., a wholly-owned subsidiary which was acquired by HPIH on July 14, 2014.  The term “ASIA” refers to American Service Insurance Agency, LLC, a wholly-owned subsidiary which was acquired by HPIH on August 8, 2014. HPIH, ICE, Secured, HP and ASIA are consolidated subsidiaries of HII, and SIL was a consolidated subsidiary of HII until March 23, 2015.
	Business Description and Organizational Structure of the Company
	Our Business
	We are a leading developer, distributor and virtual administrator of affordable, cloud-based individual health insurance plans and ancillary products.  Our subsidiary HP operates a comprehensive consumer comparison shopping website for health insurance plans, HealthPocket.com.  We are a developer and distributor of short-term medical (“STM”) insurance plans, which provide up to six, eleven or twelve months of health insurance coverage with a wide range of deductible and copay levels. STM plans generally offer qualifying individuals comparable benefits for fixed short-term durations with premiums that are substantially less than the premiums of individual major medical (“IMM”) plans which offer lifetime renewable coverage. STM plans feature a streamlined underwriting process offering immediate coverage options. Our sales of STM products are supplemented with additional production offerings. In addition to STM plans, we offer guaranteed-issue and underwritten hospital indemnity plans for individuals under the age of 65, which pay fixed cash benefits for covered procedures and services and a variety of ancillary products such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, and life insurance policies that are frequently purchased as supplements to STM and hospital indemnity plans. We also offer supplemental deductible and gap protection plans for consumers whose IMM plans may not cover certain medical expenses until high deductibles are met. We design and structure these products on behalf of insurance carriers and market them to individuals through our internal and external distribution network. We manage member relations via our online member portal, which is available 24 hours a day, seven days a week. Our online enrollment process allows us to aggregate and analyze consumer data and purchasing habits to track market trends and drive product innovation. Our sales are primarily executed online and offer real-time fulfillment through a proprietary web-based technology platform, through which we receive credit card and automated clearing house (“ACH”) payments directly from the purchasing customers, whom are also referred to as members, at the time of sale. The plans are underwritten by contracted insurance carriers, and we assume no underwriting or insurance risk. Our sales of STM and ancillary products focus on the large and under-penetrated segment of the U.S. population who are uninsured or underinsured, which includes individuals not covered by employer-sponsored insurance plans, such as the self-employed as well as small business owners and their employees, individuals who are unable to afford IMM premiums, underserved “gap populations” that require insurance due to changes caused by life events: new graduates, divorcees, early retirees, military discharges, the unemployed, part-time and seasonal employees and customers seeking health insurance between the open enrollment periods held each year by the health insurance exchanges (the “Exchanges”) created under the Patient Protection and Affordable Care Act (“PPACA”).
	We acquired HP in July 2014. HP provides consumers with access to its leading health insurance information search and comparison technology through its website, HealthPocket.com. This free website allows consumers to easily and clearly compare and rank all health insurance plans available for an individual, family, or small business, empowering consumers to make health plan decisions and reduce their out of pocket costs. HP also enhances our consolidated business operations by aggregating high-quality product sales referrals for STM and other health insurance products and ancillary products. In addition, the data aggregated by HP is used to research consumer needs and to measure product demand to help us design and manufacture high-demand insurance products.
	Our History
	Our business began operations in 2008, and historically we operated through Health Plan Intermediaries, LLC (“HPI”). HII was incorporated in the State of Delaware in October 2012 to facilitate the initial public offering (“IPO”) of our common stock. In November 2012, through a series of transactions, HPI assigned the operating assets of our business to HPIH, and HPIH assumed the operating liabilities of HPI. Since November 2012, we have operated our business through HPIH and its consolidated subsidiaries.
	Upon completion of the IPO, HII became a holding company, the principal asset of which is its interest in HPIH. All of HII’s business is conducted through HPIH and HPIH’s subsidiaries. HII is the sole managing member and has 100% of the voting rights and control of HPIH. See Note 6 for more information about the IPO.
	Basis of Presentation
	The condensed consolidated financial statements reflect the accounts of the Company. Intercompany accounts and transactions have been eliminated in consolidation.
	Noncontrolling interests are included in the consolidated balance sheets as a component of stockholders’ equity that is not attributable to the equity of the Company. We report separately the amounts of consolidated net loss or income attributable to us and noncontrolling interests.
	As an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), we benefit from certain temporary exemptions from various reporting requirements, including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act and reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements. We have also elected under the JOBS Act to delay the adoption of new and revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies.  As a result of this election, our financial statements may not be comparable to companies that comply with public company effective dates. These exemptions will apply for a period of five years following the completion of our IPO. However, if the market value of our common stock that is held by non-affiliates exceeds $700 million as of any June 30 before that time, we would cease to be an emerging growth company as of the following December 31.
	The information included in this quarterly report, including the interim condensed consolidated financial statements and the accompanying notes, should be read in conjunction with the audited consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014.
	Reclassifications
	Certain amounts in the prior period’s consolidated financial statements have been reclassified to conform to the current period presentation. Such reclassifications include excluding amounts payable for third-party commission expense from cash held on behalf of others and including such amounts in cash and cash equivalents in the accompanying condensed consolidated balance sheets and statements of cash flows, and fair value adjustment for contingent consideration as a separate component in the accompanying consolidated statements of operations, as compared to a component of other income (expense) in the prior period.
	Use of Estimates
	The accompanying unaudited interim condensed consolidated financial statements of the Company include all normal recurring accruals and adjustments considered necessary by management for their fair presentation in conformity with accounting principles generally accepted in the United States of America (“GAAP”). Preparing financial statements in accordance with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates. The consolidated results of operations for the three months ended March 31, 2015 are not necessarily indicative of results that may be expected for the year ending December 31, 2015 or any future interim period.
	Summary of Significant Accounting Policies
	The following is an update to our significant accounting policies are described in Note 1, Organization, Basis of Presentation, and Summary of Significant Accounting Policies, in our audited consolidated financial statements for the year ended December 31, 2014 included in our Annual Report on Form 10-K.
	Property and equipment, net
	Included in property and equipment, net are website development costs. These costs incurred in the development of websites are either expensed as incurred or capitalized depending on the nature of the cost and the stage of development of the project under which a website or websites are developed.  Generally, the costs incurred during the planning stage are expensed as incurred; the costs incurred for activities during the website application and infrastructure development stage are capitalized; costs incurred during the graphics development stage are capitalized if such costs are for the creation of initial graphics for the website; subsequent updates to the initial graphics are expensed as incurred, unless they provide additional functionality; costs incurred during the content development stage are expensed as incurred unless they are for the integration of a database with the website, which are capitalized; and, the costs incurred during the operating stage are expensed as incurred.
	Upon reaching the operating phase of the website application and infrastructure phase, the capitalized costs are amortized over the estimated useful life of the capitalized costs, which we expect to be five years.
	During the three months ended March 31, 2015, we capitalized $493,000 of costs incurred in the development of a website for which the software underlying the website will not be marketed externally.  This balance is included in property and equipment, net on the accompanying condensed consolidated balance sheets.  Substantially all of the costs incurred during the period were part of the website application phase, and as of March 31, 2015, the operating phase of the website has not commenced.  As such, no amortization has been recorded on the capitalized website development costs.
	Recent Accounting Pronouncements
	In the following summary of recent accounting pronouncements, all references to effective dates of Financial Accounting Standards Board (“FASB”) guidance relate to nonpublic entities. As noted above, we have elected to delay the adoption of new and revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies under provisions of the JOBS Act.
	In February 2015, the FASB issued an amendment to its accounting guidance related to financial statement consolidation.  This guidance affects reporting entities that are required to evaluate whether they should consolidate certain legal entities. Specifically, it modifies the evaluation of whether limited partnerships and similar legal entities are variable interest entities (“VIEs”) or voting interest entities, eliminates the presumption that a general partner should consolidate a limited partnership and affects the consolidation analysis of reporting entities that are involved with certain VIEs. This guidance is effective for fiscal years beginning after December 15, 2016. Early adoption is permitted. We are currently evaluating the impact of this guidance on our condensed consolidated financial statements.
	In May 2014, the FASB issued an amendment to its accounting guidance related to revenue recognition. The amendment clarifies the principles for recognizing revenue. The guidance is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in the judgments and assets recognized from costs incurred to obtain or fulfill a contract. We will adopt this guidance in reporting periods beginning after December 15, 2017. We are currently evaluating the impact of adopting this pronouncement on our consolidated financial statements.
	In April 2014, the FASB issued guidance related to discontinued operations reporting.  The new guidance changes the definition and reporting of discontinued operations to include only those disposals that represent a strategic shift and that have a major effect on an entity's operations and financial results. The new guidance, which also requires additional disclosures, becomes effective for annual periods beginning on or after December 15, 2015 and interim periods within those years and allows for early adoption.  We adopted this guidance as of January 1, 2015, and as a result determined that our disposition of our interest in SIL, which is described in Note 3, was not a strategic shift in, nor did it have a major effect on our operations or financial results.  As such, we did not treat SIL as a discontinued operation in our condensed consolidated financial statements.

Business_Acquisitions

Business Acquisitions	3 Months Ended
	Mar. 31, 2015
Business Combinations [Abstract]
Business Acquisitions	2. Business Acquisitions
	Acquisition of HealthPocket, Inc.
	On July 14, 2014, we entered into an agreement to acquire (the “Merger Agreement”) HP from Mr. Bruce Telkamp (“Telkamp”), Dr. Sheldon Wang (“Wang”) and minority equity holders of HP. The closing of the acquisition occurred on July 14, 2014 simultaneous with the signing of the Merger Agreement.
	Pursuant to the Merger Agreement, at the closing, we paid consideration consisting of approximately $21.9 million in cash and 900,900 shares of Class A common stock, $0.001 par value per share, with such shares of the  Class A common stock having an agreed upon aggregate value of $10.0 million, or $11.10 per share, which had a fair value of approximately $6.7 million as of the acquisition date. A portion of the merger consideration consisting of $3.2 million in cash was deposited with an escrow agent to fund payment obligations with respect to post-closing working capital adjustments, post-closing indemnification obligations of HP’s former equity holders, and fees and expenses of the representative of HP’s former equity holders.
	All vested options and warrants to acquire shares of HP’s capital stock were terminated in connection with the acquisition, and the holders thereof received in cash a portion of the aggregate consideration upon the terms and subject to the conditions set forth in the Merger Agreement. All unvested options to acquire shares of HP’s capital stock were converted into options to acquire shares of our Class A common stock (“Replacement Options”) upon the terms and subject to the conditions set forth in the Merger Agreement. The total number of Replacement Options was 84,909. Pursuant to the Merger Agreement, this amount offset the total number of shares included in the consolidation. If any Replacement Options are terminated or expire, the value of those options will be classified as an adjustment to the purchase price for the acquisition. The Replacement Options are included as a component of stock-based compensation on the accompanying condensed consolidated statements of operations. See Note 7 for future information on the Replacement Options. As of March 31, 2015, the net amount of shares of Class A common stock issued as a result of the acquisition was 815,991.
	Under the terms of the Merger Agreement, the former equity holders of HP had the right to elect to receive cash or shares of our Class A common stock. Telkamp and Wang agreed to accept cash and common stock, including 50% each of any of the shares that were issued as part of the aggregate consideration were not elected to be received as consideration by other former HP equity holders.
	Effective July 14, 2014, HII's Board of Directors appointed Telkamp as our Chief Operating Officer and we entered into an employment agreement with Telkamp where he also agreed to continue to serve as HP’s Chief Executive Officer.   Telkamp’s employment agreement provides for, among other things, a noncompetition covenant beginning on July 14, 2014 and ending on the last day of any salary continuation period (as defined in Telkamp’s employment agreement).  In addition, the Merger Agreement provides for, among other things, a noncompetition covenant applicable to Telkamp beginning on July 14, 2014 and ending on July 14, 2017.  Telkamp was also appointed as a member of HII’s Board of Directors on July 14, 2014 and will rotate being appointed to the Board of Directors annually with Wang pursuant to the Merger Agreement. On May 4, 2015, Telkamp’s employment agreement was amended, and he became the Chief Executive Officer of our Consumer Division.  Telkamp will continue to serve as Chief Executive Officer of HP.  In addition, effective July 14, 2014, HII’s Board of Directors appointed Wang as our Chief Technology Officer and we entered into an employment agreement with Wang where he also agreed to continue to serve as HP’s President.  Wang’s employment agreement provides for, among other things, a noncompetition covenant beginning on July 14, 2014 and ending on the last day of any salary continuation period (as defined in Wang’s employment agreement).  In addition, the Merger Agreement provides for, among other things, a noncompetition covenant applicable to Wang beginning on July 14, 2014 and ending on July 14, 2017.
	This transaction is expected to provide us with additional benefits such as increased and ongoing sales referrals that we will own, broad consumer and industry data to facilitate our entry into new markets and revenue streams, advanced health information technology to position us to better assist our stakeholders, including customers, insurance brokers and insurance carriers, and other technological and operational synergies.
	The following table summarizes the fair value of the consideration for the acquisition as of July 14, 2014 ($ in thousands):
	Cash paid at closing (1)	$	21,901
	Class A common stock, at fair value (2)		6,734
	Total consideration	$	28,635
	-1	Cash paid at closing includes $17.0 million in cash, $3.2 million in cash held in escrow, as noted above, $1.2 million for the payoff of outstanding bank debt held by HP, $54,000 for the payoff of HP loans payable to Telkamp and Wang, and $482,000 in estimated acquisition-related expenses incurred by HP.
	-2	The fair value of the Class A common stock derived from the market price of the stock, adjusted to include a discount for a lack of marketability, due to trading restrictions pursuant to the Merger Agreement and other factors.
	The following table summarizes the allocation of the total purchase price for the acquisition as of July 14, 2014 ($ in thousands):
	Cash	$	1,294
	Accounts receivable and other assets (1)		104
	Property and equipment (1)		6
	Accounts payable, accrued expenses and other liabilities (1)		(480	)
	Deferred tax liability – long-term		(2,967	)
	Intangible asset – technology		8,000
	Intangible asset – brand		1,280
	Intangible asset – customer relationships		430
	Intangible asset – noncompete agreements		27
	Goodwill (2)		20,941
		$	28,635
	-1	The carrying value of accounts receivable, accounts payable, accrued expenses and property and equipment approximated fair value; as such, no adjustments to the accounts were recorded in association with the acquisition.
	-2	As of March 31, 2015, we expect none of the goodwill acquired in this transaction to be deductible for income tax purposes.
	The goodwill allocated to the purchase price was calculated as the fair value of the consideration less the assets acquired and liabilities assumed. This value is primarily related to the expected results of future operations of HP and the operational and technological synergies we expect to realize as a result of the acquisition.
	As a result of acquiring HP, our consolidated results of operations include the results of HP since the acquisition date. HP’s revenues and pre-tax net loss included in our results of operations for the three months ended March 31, 2015 are $664,000 and $961,000. Net loss before taxes included $316,000 of amortization expense related to the identified intangible assets recorded as a result of the acquisition.
	Acquisition of ASIA
	On August 8, 2014, we entered into an agreement (the “ASIA Purchase Agreement”) to acquire all of the issued and outstanding membership interests of ASIA, a Texas insurance brokerage, from Mr. Landon Jordan (“Jordan”) for an initial cash payment of $1.8 million, comprised of a prior deposit of $325,000 and a closing payment of $1.5 million, and $2.2 million in contingent consideration, as described below.  The closing of the acquisition occurred on August 8, 2014 simultaneous with the signing of the ASIA Purchase Agreement.
	Pursuant to the ASIA Purchase Agreement, Jordan may receive total contingent consideration of $2.2 million, payable in cash.  This amount is payable in two cash payments of $1.2 million and $1.0 million, respectively, if ASIA attains certain amounts of adjusted EBITDA, as defined in the ASIA Purchase Agreement, during each of the periods from September 1, 2014 through August 31, 2015, and September 1, 2015 through August 31, 2016.  The estimated range of potential total contingent consideration is zero to approximately $2.2 million.
	During the three months ended March 31, 2015, we determined that it was not probable that ASIA will attain the required amounts of adjusted EBITDA during the period from September 1, 2014 through August 31, 2015 for Jordan to earn the contingent consideration payment of $1.2 million noted above.  However, we believe that it is probable we will make a contingent consideration payment of $500,000 related to ASIA’s results for the year ended December 31, 2015 in lieu of the existing contingent consideration terms under the ASIA Purchase Agreement.  We believe it is probable that Jordan will earn the payment of the contingent consideration of $1.0 million related to the period from September 1, 2015 through August 31, 2016.  As of March 31, 2015, the fair value of the contingent consideration was $864,000 which is included in contingent acquisition consideration on the accompanying condensed consolidated balance sheets.  During the three months ended March 31, 2015, we recorded a $529,000 reduction to the fair value of the contingent consideration, primarily due to a decrease in the estimated probability of ASIA to achieve the adjusted EBITDA thresholds necessary to require payment of the contingent consideration to Jordan.
	Effective August 8, 2014, we also entered into an employment agreement with Jordan which provides for, among other things, a noncompetition covenant beginning on August 8, 2014 and ending on the later of August 8, 2017 and one year following the date on which Jordan’s employment with us is terminated.
	The following table summarizes the fair value of the consideration for the acquisition as of August 8, 2014 ($ in thousands):
	Cash paid at closing	$	1,825
	Contingent consideration, at fair value		1,263
	Total consideration	$	3,088
	The following table summarizes the allocation of the total purchase price for the acquisition as of August 8, 2014 ($ in thousands):
	Cash	$	105
	Accounts receivable and other assets (1)		271
	Accounts payable, accrued expenses and other liabilities  (1)		(163	)
	Intangible asset – customer relationships – distributors		449
	Intangible asset – customer relationships – direct		266
	Intangible asset – brand		21
	Intangible asset – noncompete agreements		18
	Goodwill (2)		2,121
		$	3,088
	-1	The carrying value of accounts receivable, accounts payable, accrued expenses and property and equipment approximated fair value; as such, no adjustments to the accounts were recorded in association with the acquisition.
	-2	As of March 31, 2015, the amount of goodwill acquired that we expect to be deductible for income tax purposes is $840,000.
	The goodwill allocated to the purchase price was calculated as the fair value of the consideration less the assets acquired and liabilities assumed. This value is primarily related to expected results of future operations of ASIA and the operational and technological synergies we expect to realize as a result of the acquisition.
	As a result of acquiring ASIA, our consolidated results of operations include the results of ASIA since the acquisition date. ASIA’s revenues and pre-tax net loss included in our results of operations was $921,000 and $285,000, respectively, for the three months ended March 31, 2015. Net loss before taxes include $45,000 of amortization expense related to the identified intangible assets recorded as a result of the acquisition.

Variable_Interest_Entities

Variable Interest Entities	3 Months Ended
	Mar. 31, 2015
Variable Interest Entity Measure Of Activity [Abstract]
Variable Interest Entities	3. Variable Interest Entities
	As of March 31, 2015, we are the primary beneficiary of one entity that constitutes a VIE pursuant to FASB guidance.
	HPIH
	As of March 31, 2015, we had a variable interest in HPIH. HPIH is a VIE as the voting rights of the investors are not proportional to their obligations to absorb the expected losses of HPIH. We hold 100% of the voting power in HPIH, but 52.8% of the total membership and economic interest, and the other members of HPIH hold no voting rights in HPIH. Further, substantially all of the activities of HPIH are conducted on behalf of a membership with disproportionately few voting rights. We have concluded that we are the primary beneficiary of HPIH, and, therefore, should consolidate HPIH since we have power over and receive the benefits of HPIH. We have the power to direct the activities of HPIH that most significantly impact its economic performance. Our equity interest in HPIH obligates us to absorb losses of HPIH and gives us the right to receive benefits from HPIH related to the day-to-day operations of the entity, both of which could potentially be significant to HPIH. As such, our maximum exposure to loss as a result of our involvement in this VIE is the net income or loss allocated to us based on our interest.
	SIL
	On October 7, 2013, HPIH entered into a Limited Liability Company Operating Agreement (the “SIL LLC Agreement”) with Health Benefits One, LLC (“HBO”) in connection with the formation of SIL, a venture intended to procure sales leads for us and our distributors. We had made $492,000 in contributions to SIL during the years ended December 31, 2013 and 2013. In addition, we entered into an agreement to loan $185,000 to SIL, which can be repaid via offset of earned commissions of HBO otherwise payable by us. HBO had no obligations to make any initial capital contributions. Per the SIL LLC Agreement, so long as HPIH’s unreturned capital contributions had not been reduced to zero, HPIH could, without the consent of HBO, cause SIL to take any significant actions affecting SIL’s day-to-day operations, including the sale or disposition of SIL assets and entrance into voluntary liquidation or receivership of SIL. As such, we determined that we had the power to control the day-to-day activities of SIL.
	We concluded that we were the primary beneficiary of SIL, and therefore, we consolidated SIL because we had power over and receive the benefits of SIL. We had the power to direct the activities of SIL that most significantly impact its economic performance. Per the terms of the SIL LLC Agreement, we determined that 100% of the operating income or loss of the VIE should be allocated to us.
	On March 23, 2015, we entered into a Unit Purchase Agreement (the “Unit Purchase Agreement”) to sell our interests in SIL to HBO in exchange for a note receivable from HBO with a face amount of $246,000 and the right to receive certain contingent consideration.  The parties have agreed that this note will be payable with credits against sales commissions due to HBO, and any such commissions earned during the term of the note will be applied against the outstanding balance payable to us under the note. As such, the note is included in advanced commissions in the accompanying consolidated balance sheets.  In addition, we may receive contingent consideration equal to 10.0% of SIL’s earnings before interest, taxes, depreciation and amortization, as defined in the Unit Purchase Agreement for each of the fiscal years ended December 31, 2015 and 2016, respectively.  The amounts receivable as contingent consideration are not estimable nor reasonably assured; as such, we have not recorded the contingent consideration on our consolidated balance sheets.
	As a result of the sale of our interest, we no longer have any ownership interest in SIL and have deconsolidated SIL from our consolidated financial statements.  The results of operations of SIL are included in the accompanying consolidated financial statements through the date of the Unit Purchase Agreement.  We recorded a gain of $189,000 on the sale representing the difference between the consideration received and the carrying value of SIL’s net assets at the time of the transaction.

Goodwill_and_Intangible_Assets

Goodwill and Intangible Assets	3 Months Ended
	Mar. 31, 2015
Goodwill And Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	4. Goodwill and Intangible Assets
	Goodwill
	Our goodwill balance as of March 31, 2015 and December 31, 2014 arose from previous acquisitions as described in our annual report on Form 10-K for the year ended December 31, 2014. Our goodwill balance as of March 31, 2015 arose from the HP and the ASIA acquisitions described in Note 2 as well as our goodwill balance existing as prior to such acquisitions.
	The changes in the carrying amounts of goodwill by operating segment are as follows ($ in thousands):
		IPD		HP			Total
	Balance as of January 1, 2014	$	18,014	$	-		$	18,014
	Goodwill acquired		2,121		20,941			23,062
	Impairment of goodwill		—		—			—
	Balance as of December 31, 2014		20,135		20,941			41,076
	Goodwill acquired		—		—			—
	Impairment of goodwill		—		—			—
	Balance as of March 31, 2015	$	20,135	$	20,941		$	41,076
	Other Intangible Assets
	Our other intangible assets arose primarily from the acquisitions described above and consist of a brand, the carrier network, distributor relationships, customer relationships, noncompete agreements and capitalized software. Finite-lived intangible assets are amortized over their useful lives from two to fifteen years.
	Major classes of intangible assets as of March 31, 2015 consisted of the following ($ in thousands):
		Weighted-average Amortization (years)			Gross Carrying Amount				Accumulated Amortization			Intangible Assets, net
	Brand		14.1		$	1,377			$	(136	)	$	1,241
	Carrier network		5			40				(28	)		12
	Distributor relationships		9.3			5,109				(1,945	)		3,164
	Noncompete agreements		4.7			987				(517	)		470
	Customer relationships		5.8			1,484				(783	)		701
	Capitalized software		6.7			8,571				(1,330	)		7,241
	Total intangible assets		7.8		$	17,568			$	(4,739	)	$	12,829
	Major classes of intangible assets as of December 31, 2014 consisted of the following ($ in thousands):
		Weighted-average Amortization (years)			Gross Carrying Amount				Accumulated Amortization			Intangible Assets, net
	Brand		14.1		$	1,377			$	(103	)	$	1,274
	Carrier network		5			40				(26	)		14
	Distributor relationships		9.3			5,109				(1,791	)		3,318
	Noncompete agreements		4.7			987				(462	)		525
	Customer relationship		5.8			1,484				(644	)		840
	Capitalized software		6.7			8,571				(977	)		7,594
	Total intangible assets		7.8		$	17,568			$	(4,003	)	$	13,565
	Amortization expense for the three months ended March 31, 2015 and 2014 was $736,000 and $375,000, respectively.
	Estimated annual pretax amortization of intangible assets for the remainder of 2015 and in each of the next five years are as follows ($ in thousands):
	Remainder of 2015	$	1,907
	2016		2,173
	2017		1,984
	2018		1,743
	2019		1,357
	2020		1,357
	Thereafter		2,308
	Total	$	12,829

Accounts_Payable_and_Other_Lia

Accounts Payable and Other Liabilities	3 Months Ended
	Mar. 31, 2015
Payables And Accruals [Abstract]
Accounts Payable and Other Liabilities	5. Accounts Payable and Other Liabilities
	Accounts payable and accrued expenses consisted of the following as of ($ in thousands):
		31-Mar-15		31-Dec-14
	Accounts payable	$	594	$	906
	Carriers and vendors payable		4,766		5,830
	Commissions payable		1,704		2,009
	Accrued wages		646		1,062
	Accrued refunds		708		815
	Accrued credit card/ACH fees		127		144
	Accrued interest		-		1
	Accrued professional fees		259		198
	Other accruals		526		432
	Total accounts payable and accrued expenses	$	9,330	$	11,397

Stockholders_Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2015
Stockholders Equity Note [Abstract]
Stockholders' Equity	6. Stockholders’ Equity
	On February 13, 2013, we completed our IPO by issuing 4,666,667 shares of our Class A common stock, par value $0.001 per share, at a price to the public of $14.00 per share of Class A common stock. In addition, we issued 8,666,667 shares of our Class B common stock, of which 8,580,000 shares of Class B common stock were obtained by HPI, and 86,667 shares of Class B common stock were obtained by Health Plan Intermediaries Sub, LLC (“HPIS”), of which HPI is the managing member. In addition, we granted the underwriters of the IPO the right to purchase additional shares of Class A common stock to cover over-allotments (the “over-allotment option”).
	Our authorized capital stock consists of 100,000,000 shares of Class A common stock, par value $0.001 per share, 20,000,000 shares of Class B common stock, par value $0.001 per share, and 5,000,000 shares of preferred stock, par value $0.001 per share.
	Class A Common Stock and Class B Common Stock
	Each share of Class A common stock and Class B common stock entitles its holders to one vote per share on all matters to be voted upon by the stockholders, and holders of each class will vote together as a single class on all such matters. Holders of shares of our Class A common stock and Class B common stock vote together as a single class on all matters presented to our stockholders for their vote or approval, except as otherwise required by applicable law. As of March 31, 2015, the Class A common stockholders had 52.8% of the voting power in HII and the Class B common stockholders had 47.2% of the voting power in HII. Holders of shares of our Class A common stock have 100% of the economic interest in HII. Holders of Class B common stock do not have an economic interest in HII.
	The determination to pay dividends, if any, to our Class A common stockholders will be made by our Board of Directors. We do not, however, expect to declare or pay any cash or other dividends in the foreseeable future on our Class A common stock, as we intend to reinvest any cash flow generated by operations in our business. We may enter into credit agreements or other borrowing arrangements in the future that prohibit or restrict our ability to declare or pay dividends on our Class A common stock. In the event of liquidation, dissolution, or winding up of HII, the holders of Class A common stock are entitled to share ratably in all assets remaining after payment of liabilities, subject to prior distribution rights of preferred stock, if any, then outstanding. The holders of our Class A common stock have no preemptive or conversion rights or other subscription rights. There are no redemption or sinking fund provisions applicable to the Class A common stock. The rights, preferences and privileges of holders of our common stock will be subject to those of the holders of any shares of our preferred stock we may issue in the future.
	Class B common stockholders will not be entitled to any dividend payments. In the event of any dissolution, liquidation, or winding up of our affairs, whether voluntary or involuntary, after payment of our debts and other liabilities and making provision for any holders of our preferred stock that have a liquidation preference, our Class B common stockholders will not be entitled to receive any of our assets. In the event of our merger or consolidation with or into another company in connection with which shares of Class A common stock and Class B common stock (together with the related membership interests) are converted into, or become exchangeable for, shares of stock, other securities or property (including cash), each Class B common stockholder will be entitled to receive the same number of shares of stock as is received by Class A common stockholders for each share of Class A common stock, and will not be entitled, for each share of Class B common stock, to receive other securities or property (including cash). No holders of Class B common stock will have preemptive rights to purchase additional shares of Class B common stock.
	The following table presents the effects of changes in HII’s ownership interests in HPIH and its consolidated subsidiaries on its equity ($ in 000’s):
		Three months ended March 31,
		2015			2014
	Net income (loss) attributable to Health Insurance Innovations, Inc.	$	53		$	(74	)
	Distributions		(319	)		(5	)
	Total	$	(266	)	$	(79	)
	Exchange Agreement
	On February 13, 2013, we entered into an exchange agreement (the “Exchange Agreement”) with the holders of the Series B Membership Interests of HPIH (“Series B Membership Interests”). Pursuant to and subject to the terms of the Exchange Agreement and the amended and restated limited liability company agreement of HPIH, holders of Series B Membership Interests, at any time and from time to time, may exchange one or more Series B Membership Interests, together with an equal number of shares of our Class B common stock, for shares of our Class A common stock on a one-for-one basis, subject to equitable adjustments for stock splits, stock dividends and reclassifications. See Note 1 from our December 31, 2014 audited consolidated financial statements included in our annual report on Form 10-K for the year ended December 31, 2014 for further information on the Exchange Agreement.
	Holders will not have the right to exchange Series B Membership Interests if we determine that such exchange would be prohibited by law or regulation or would violate other agreements to which we may be subject. We may impose additional restrictions on exchanges that we determine necessary or advisable so that HPIH is not treated as a “publicly traded partnership” for U.S. federal income tax purposes. If the Internal Revenue Service were to contend successfully that HPIH should be treated as a “publicly traded partnership” for U.S. federal income tax purposes, HPIH would be treated as a corporation for U.S. federal income tax purposes and thus would be subject to entity-level tax on its taxable income.
	A holder that exchanges Series B Membership Interests will also be required to deliver an equal number of shares of our Class B common stock. In connection with each exchange, HPIH will cancel the delivered Series B Membership Interests and issue to us Series A Membership Interests on a one-for-one basis. Thus, as holders exchange their Series B Membership Interests for Class A common stock, our interest in HPIH will increase.
	In accordance with the Exchange Agreement, in March 2013, we received a net amount of $1.4 million in proceeds from the issuance of 100,000 shares of Class A common stock through the underwriter’s exercise of its over-allotment option in connection with our IPO. We immediately used the proceeds to acquire Series B Membership Interests, together with an equal number of shares of our Class B common stock from HPI. These Series B Membership Interests were immediately recapitalized into Series A Membership Interests in HPIH.
	On February 1, 2014, a registration statement on Form S-3 became effective under which we registered 8,566,667 shares of our Class A common stock for resale from time to time by the selling stockholders, of which all such shares are issuable upon the exchange of an equivalent number of Series B Membership Interests (together with an equal number of shares of our Class B common stock).
	On August 15, 2014, we entered into an underwriting agreement with Raymond James & Associates, Inc., as the underwriter, and HPI and HPIS, as selling stockholders (the “Selling Stockholders”).  Pursuant to the underwriting agreement and the Exchange Agreement, we issued 1,725,000 shares of Class A common stock, at a public offering price of $12.15 per share ($11.54 per share, net of underwriting discounts), for net proceeds of $19.9 million.  We immediately used these proceeds to acquire Series B Membership Interests, together with an equal number of shares of our Class B common stock from the Selling Stockholders.  These Series B Membership Interests were immediately recapitalized into Series A Membership Interests in HPIH. The Selling Stockholders agreed to sell to the underwriter for resale all 1,725,000 shares of Class A common stock.  No shares were sold by the Company in this offering, and the Company did not receive any of the proceeds from the sale by the Selling Stockholders.  The sale by the Selling Stockholders was made pursuant to the registration statement on Form S-3 described above.  No other shares of Class A common stock have been issued or sold pursuant to the registration statement on Form S-3.
	Preferred Stock
	Our board of directors has the authority to issue shares of preferred stock in one or more series and to fix the rights, preferences, privileges and restrictions thereof, including dividend rights, dividend rates, conversion rights, voting rights, terms of redemption, redemption prices, liquidation preferences and the number of shares constituting any series or the designation of such series, without further vote or action by the stockholders.
	The issuance of preferred stock may have the effect of delaying, deferring or preventing a change in control of HII without further action by the stockholders and may adversely affect the voting and other rights of the holders of Class A common stock. At present, we have no plans to issue any preferred stock.
	Treasury Stock
	Treasury stock is recorded at cost.  As of March 31, 2015 and December 31, 2014, we held 269,729 and 47,144 shares of treasury stock, respectively, recorded at a cost of $2.8 million and $347,000, respectively.
	Share Repurchase Program
	On December 17, 2014, our Board of Directors authorized us to purchase up to 800,000 shares of our registered Class A common stock under a repurchase program which could remain in place until December 31, 2016. We have adopted a plan (the “Repurchase Plan”) under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), in connection with this authorization.  The Repurchase Plan allows us to repurchase our shares of Class A common stock at times when we otherwise might be prevented from doing so under insider trading laws or self-imposed trading blackout periods.
	During the three months ended March 31, 2015, we repurchased 67,152 shares of our registered Class A common stock under the Repurchase Plan at an average price per share of $7.17.
	Tax Obligation Settlements and Treasury Stock Transactions
	Treasury stock is recorded pursuant to the surrender of shares by certain employees to satisfy statutory tax withholding obligations on vested restricted stock awards. In addition, certain forfeited stock-based awards are transferred to and recorded as treasury stock, and certain restricted stock awards have been granted from shares in Treasury, and certain forfeited awards.
	During the three months ended March 31, 2015, 5,433 shares were transferred to Treasury as a result of surrendered shares of vested restricted stock awards, and 150,000 shares were transferred to Treasury as the result of forfeitures of restricted stock awards. During the three months ended March 31, 2014, 9,887 shares were transferred to Treasury as a result of surrendered shares of vested restricted stock awards.

Stockbased_Compensation

Stock-based Compensation	3 Months Ended
	Mar. 31, 2015
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock-based Compensation	7. Stock-based Compensation
	We maintain one stock-based incentive plan, the Health Insurance Innovations, Inc. Long Term Incentive Plan (the “LTIP”), which became effective February 7, 2013, under which restricted stock, stock appreciation rights (“SARs”), stock options and other types of equity and cash incentive awards may be granted to employees, non-employee directors and service providers. The LTIP expires after ten years, unless prior to that date the maximum number of shares available for issuance under the LTIP have been issued or our Board of Directors terminates the LTIP. There were 1,250,000 shares of Class A common stock reserved for issuance under the LTIP.
	Expense for stock-based compensation is recognized based upon estimated grant date fair value and is amortized over the service period of the awards using the accelerated method. For grants of SARs and options, we apply the Black-Scholes option-pricing model in determining the fair value of share-based payments to employees. The resulting compensation expense is recognized over the period. The requisite service period is the period during which an employee is required to provide service in exchange for an award, which often is the vesting period. Compensation expense is recognized only for those awards expected to vest, with forfeitures estimated based on our historical experience and future expectations. All stock-based compensation expense is classified within selling, general and administrative (“S, G & A”) expense in the consolidated statements of operations. None of the stock-based compensation was capitalized during the three months ended March 31, 2015 and 2014, respectively.
	The expected term of the awards represents the estimated period of time until exercise, giving consideration to the contractual terms, vesting schedules and expectations of future employee behavior. For the three months ended March 31, 2015 and 2014, the expected stock price volatility was determined using a peer group of public companies within our industry as we believe this method better approximates the long-term volatility of our stock. In the short time since our IPO, our stock has been subject to large fluctuations due to a small percentage of shares available for trading, resulting in a low trading volume. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant with an equivalent remaining term. We have not paid dividends in the past and do not currently plan to pay any dividends in the foreseeable future.
	The Black-Scholes option-pricing model was used with the following weighted average assumptions:
		Three months ended
		March 31,
		2015			2014
	Risk-free interest rate		1.6	%		1.2	%
	Expected life	4.9 years			4.7 years
	Expected volatility		40.7	%		44	%
	Expected dividend yield	none			none
	The following table summarizes restricted shares, SARs, and stock options granted during the three months ended March 31, 2015 and 2014 (in thousands):
		Three months ended
		March 31,
		2015			2014
	SARs issued		—			—
	Restricted shares issued		10			—
	Stock options issued		—			—
	During the three months ended March 31, 2015, 175,000 SAR and 150,000 restricted share awards were forfeited.  All of these awards were unvested.  No SARs were exercised during the three months ended March 31, 2015. There were no forfeitures and no SARs were exercised during the three months ended March 31, 2014.
	The following table summarizes stock-based compensation expense for the three months ended March 31, 2015 and 2014 ($ in thousands):
		Three months ended
		March 31,
		2015			2014
	SARs	$	(4	)	$	203
	Restricted shares		(66	)		202
	Stock options		131			—
		$	61		$	405
	The following table summarizes unrecognized stock-based compensation and the remaining weighted average period over which such stock-based compensation is expected to be recognized as of March 31, 2015 ($ in thousands):
					Weighted Average Remaining years
	SARs	$	650			2.1
	Restricted shares		688			1.9
	Stock options		338			1.3
		$	1,676
	The amounts in the table above do not include the cost of any additional awards that may be granted in future periods.
	For the three months ended March 31, 2015 and 2014, the settlement of stock based incentive plans resulted in a cash outflow of $35,000 and $117,000, respectively, with respect to shares redeemed to cover the recipient’s tax obligations. We recognized an income tax benefit of $54,000 and $47,000 from stock-based activity for the three months ended March 31, 2015 and 2014.

Net_Income_Loss_per_Share

Net Income (Loss) per Share	3 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Net (Loss) Income per Share	8. Net Income (Loss) per Share
	The computations of basic and diluted net income (loss) per share attributable to HII for the three months ended March 31, 2015 and 2014 were as follows ($ in thousands, except share and per share data):
		Three months ended March 31,
		2015		2014
	Basic net income (loss) attributable to Health Insurance Innovations, Inc.	$	53	$	(74	)
	Average shares—basic		7,515,053		5,025,669
	Effect of dilutive securities:
	Restricted shares		181,928		—
	Stock options		17,358		—
	Average shares—diluted		7,714,339		5,025,669
	Basic net income (loss) per share attributable to Health Insurance Innovations, Inc.	$	0.01	$	(0.01	)
	Diluted net income (loss) per share attributable to Health Insurance Innovations, Inc.	$	0.01	$	(0.01	)
	Potential common shares are included in the diluted per share calculation when dilutive. Potential common shares consist of Class A common stock issuable through unvested restricted stock grants and stock appreciation rights and are calculated using the treasury stock method. There is no effect of our restricted stock, stock options and SARs in the computation of diluted earnings per share for the three months ended March 31, 2014 due to a net loss in that period.
	The following securities were not included in the calculation of diluted net income (loss) per share because such inclusion would be anti-dilutive (in thousands):
		Three months ended March 31,
		2015		2014
	Restricted shares		14		130
	SARs		419		359
	Stock options		23		—

Income_Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Income Taxes	9. Income Taxes
	Our subsidiary, HPIH, operates in the United States as a partnership for U.S. federal and state income tax purposes, where taxation is the responsibility of its partners. As a partner in HPIH, we are subject to U.S. corporate federal, state and local income taxes that are reflected in our consolidated financial statements. The effective tax rate for the three months ended March 31, 2015 and 2014 was (414.2%) and 11.4%, respectively. Benefit for income taxes was $336,000 and $32,000 for the three months ended March 31, 2015 and 2014, respectively. The effective tax rate for the three months ended March 31, 2015 and 2014 were significantly impacted by a change in the valuation allowance provided against our deferred tax assets, as we believe it is more likely than not that some of our deferred tax assets will not be realized to offset future taxable income.
	During any period, our effective tax rate also is reduced because certain of our subsidiaries operate as limited liability companies which are not subject to federal or state income tax. Accordingly, a portion of our earnings or losses attributable to noncontrolling interests are not subject to corporate level taxes.
	We evaluate quarterly the positive and negative evidence regarding the realization of net deferred tax assets. The carrying value of our net deferred tax assets is based on our belief that it is more likely than not that we will be unable to realize some of these deferred tax assets.  As of March 31, 2015, we have determined that it is more likely than not that some of our deferred tax assets will not be realized due to the presence of losses in the only two fiscal years in which we have measured deferred tax assets.  As such, we have provided a valuation allowance against some of our deferred tax assets as of March 31, 2015.
	We project to have a current tax liability for the year resulting from our forecasted results from operations, which results primarily from expenses not currently deductible for income tax purposes. We do not project that the current tax liability will enable a significant portion of our deferred tax assets to be realized, and as such, the tax benefit that ordinarily accompanies a deferred tax asset is not available to offset the tax expense from our projected current tax liability.
	We account for uncertainty in income taxes using a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained upon audit, including resolution of related appeals or litigation processes, if any. The second step requires us to estimate and measure the tax benefit as the largest amount that is more likely than not to be realized upon ultimate settlement. Such amounts are subjective, as a determination must be made on the probability of various possible outcomes. We reevaluate uncertain tax positions on a quarterly basis. This evaluation is based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit, and new audit activity. Such a change in recognition and measurement could result in recognition of a tax benefit or an additional tax provision. During the three months ended March 31, 2015, we adopted FASB guidance which states that a liability for uncertain tax positions should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward.  If the net operating loss carryforward, similar tax loss or tax credit carryforward is unavailable as of the reporting date, then the liability for uncertain tax positions should be presented as a deferred tax liability and not combined with deferred tax assets.  This guidance did not have an impact on our financial statements as we have no uncertain tax positions as of March 31, 2015.
	For the three months ended March 31, 2015 and 2014, we had no gross unrecognized tax benefit. We believe that there will not be a significant increase or decrease to the uncertain tax positions within 12 months of the reporting date.

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2015
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies
	10. Commitments and Contingencies
	Leases
	We lease office spaces to conduct the operations of HPIH and subsidiaries which expire in between 2015 and 2019. The office space operating lease agreements contain rent holidays and rent escalation provisions. Rent holidays and rent escalation provisions are considered in determining straight-line rent expense to be recorded over the lease term. The difference between cash rent payments and straight-line rent expense was $83,000 and $60,000 as of March 31, 2015 and December 31, 2014, respectively. Total rent expense under all operating leases, which includes equipment, was $171,000 and $73,000 for the three months ended March 31, 2015 and 2014, respectively, and is included in S, G & A expenses in the accompanying condensed consolidated statements of operations.
	BimSym Agreements
	On August 1, 2012, we entered into a software assignment agreement with BimSym eBusiness Solutions, Inc. (“BimSym”) for our exclusive ownership of all rights, title and interest in the technology platform (“A.R.I.E.S. System”) developed by BimSym and utilized by us. As a result of the agreement, we purchased the A.R.I.E.S. System, our proprietary sales and member administration platforms, for $45,000 and this purchase was capitalized and recorded as an intangible asset. In connection with this agreement, we simultaneously entered into a master services agreement for the technology, under which we are required to make monthly payments of $26,000 for 5 years. After the five-year term, this agreement automatically renews for one-year terms unless we give 60 days’ notice.
	Additionally, we also entered into an exclusivity agreement with BimSym whereby neither BimSym nor any of its affiliates will create, market or sell a software, system or service with the same or similar functionality as that of the A.R.I.E.S. System under which we are required to make monthly payments of $16,000 for five years. The present value of these payments was capitalized and recorded as an intangible asset with a corresponding liability on the accompanying condensed consolidated balance sheets.
	Revolving Line of Credit
	On December 15, 2014, HPIH entered into a three-year revolving line of credit (“RLOC”) for $15.0 million with a bank. The purpose of the RLOC is to provide working capital to support our general corporate expenses and to help us maintain adequate liquidity. Borrowings under this facility are secured by all of our and our subsidiaries’ assets, including, but not limited to, cash, accounts receivable, and property and equipment. The stated interest rate for the RLOC is 30-day LIBOR, plus 1.95%. As of March 31, 2015 and December 31, 2014, HPIH had not drawn on the RLOC.
	The RLOC is subject to customary covenants and restrictions which, among other things, require us to maintain minimum working capital equal to 1.50 times the outstanding balance, and require that our maximum funded debt to tangible net worth ratio shall not exceed 1.50 at any time during the term of the RLOC. The RLOC also imposes certain nonfinancial covenants on us that would require immediate payment if we, among other things, reorganize, merge, consolidate, or otherwise change ownership or business structure without the bank’s prior written consent.
	The RLOC agreements also contain customary representations and warranties and events of default. The payment of outstanding principal under the RLOC and accrued interest thereon may be accelerated and become immediately due and payable upon default of payment or other performance obligations or failure to comply with financial or other covenants in the RLOC agreements, subject to applicable notice requirements and cure periods as provided in the RLOC agreements. HII and each of the wholly-owned subsidiaries of HPIH are guarantors of the RLOC and would be required to pay any outstanding debt under the RLOC upon the occurrence of an event of default by HPIH.
	Under the terms of the RLOC, we incurred certain costs related to acquiring the RLOC of $23,000. These costs have been capitalized and are included in accounts receivable, net, prepaid expenses and other current assets and other-long term assets on the accompany condensed consolidated balance sheets.  The deferred financing costs consist primarily of consulting and legal fees directly related to the bank loan. These amounts are amortized over the life of the RLOC.
	Tax Receivable Agreement
	On February 13, 2013, we entered into a Tax Receivable Agreement (“TRA”) with the holders of the HPIH Series B Membership Interests, which holders are beneficially owned by Michael W. Kosloske, our founder, Chairman of the Board, President and Chief Executive Officer. The TRA requires us to pay to such holders 85% of the cash savings, if any, in U.S. federal, state and local income tax we realize (or are deemed to realize in the case of an early termination payment, a change in control or a material breach by us of our obligations under the TRA) as a result of any possible future increases in tax basis and of certain other tax benefits related to entering into the TRA, including tax benefits attributable to payments under the TRA itself. This is HII’s obligation and not an obligation of HPIH. HII will benefit from the remaining 15% of any realized cash savings. For purposes of the TRA, cash savings in income tax is computed by comparing our actual income tax liability with our hypothetical liability had we not been able to utilize the tax benefits subject to the TRA itself. The TRA became effective upon completion of the IPO and will remain in effect until all such tax benefits have been used or expired, unless HII exercises its right to terminate the TRA for an amount based on the agreed payments remaining to be made under the agreement or HII breaches any of its material obligations under the TRA in which case all obligations will generally be accelerated and due as if HII had exercised its right to terminate the agreement. Any potential future payments will be calculated using the market value of our Class A common stock at the time of the relevant exchange and prevailing tax rates in future years and will be dependent on us generating sufficient future taxable income to realize the benefit. Payments are generally due under the TRA within a specified period of time following the filing of our tax return for the taxable year with respect to which payment of the obligation arises.
	Exchanges of Series B Membership Interests, together with an equal number of shares of our Class B common stock, for shares of our Class A common stock, are expected to increase our tax basis in our share of HPIH’s tangible and intangible assets. These increases in tax basis are expected to increase our depreciation and amortization deductions and create other tax benefits and therefore may reduce the amount of tax that we would otherwise be required to pay in the future.  As of March 31, 2015, Series B Membership Interests, together with an equal number of shares of Class B common stock have been exchanged for of a total of 1,825,000 shares of Class A common stock subsequent to the IPO. See Note 6 for further information on these issuances of Class A common stock.  As a result of the exchanges noted above, we have recorded a liability of $741,000 pursuant to the TRA as of March 31, 2015.  We have determined that some of this amount is probable to be paid, because a portion of the deductions and other tax benefits noted above has been utilized based on our estimated taxable income for 2014.  Therefore a portion of the valuation allowance on our deferred tax assets related to the TRA was reversed in 2014.  The exchange transactions created a tax benefit to be shared by the Company and the entities beneficially owned by Mr. Kosloske.  Our total liability pursuant to the TRA for exchange transactions completed through March 31, 2015 would be $10.8 million, representing the share of tax benefits payable to the entities beneficially owned by Mr. Kosloske, if we generate sufficient taxable income in the future.  We have made no payments under the TRA as of March 31, 2015, but plan to make payments under the TRA during the year ended December 31, 2015.
	Distributor Commission Advances
	From time to time, we enter into agreements with our distributors to make advanced commission payments to them.  Certain of these agreements include a loan agreement for the purposes of securing the advanced payments we make.  Generally, these loans will be paid by commissions earned by the distributor, as described in the respective agreements.
	In September 2014, we entered into an agreement with one of our distributors, and certain individuals and entities related to this distributor (collectively, the “Distributor”), to make advances via a variable secured promissory note. The variable secured promissory note executed by the Distributor (the “September 2014 Note”) provides for advances up to an aggregate amount of $4.8 million, payable in three installments of $1.5 million, $1.5 million, and $1.8 million, respectively.  The first advance installment of $1.5 million was made in September 2014 and is included in advanced commissions on accompanying condensed consolidated balance sheets as of March 31, 2015. The latter two installments will be made on the earlier of June 26, 2015 and February 26, 2016, respectively, or the achievement of certain levels of sales of our products, as defined in the September 2014 Note, on or before such dates.  The September 2014 Note, which secure the advances, matures on April 26, 2017 and bears interest only upon the occurrence of an event of default, as defined in the September 2014 Note.  All amounts outstanding, including interest, are due within thirty days of the maturity date, subject to acceleration upon the occurrence of an event of default.
	Under the September 2014 Note, the Distributor is eligible to earn bonus commissions for each qualifying sale of our products, as defined in the September 2014 Note. Any such bonus commissions earned during the term of the September 2014 Note will be applied against the outstanding balance payable to us under the September 2014 Note, in lieu of a cash payment to us, and the net amount (if any) will be payable to the Distributor.
	In January 2015, we entered into agreements with the Distributor to make advances via two additional variable secured promissory notes, which we refer to as the “January 2015 Production Note” and the “January 2015 MDF Note”, and collectively as the “January 2015 Variable Notes”.  The January 2015 Variable Notes provide for advances of up to $2.0 million each.  The first installments, $1,500,000 under the January 2015 Production Note and $1,000,000 under the January 2015 MDF Note, were made in January 2015.  Both January 2015 Variable Notes provide for second installments of $500,000 each, payable on July 1, 2015, and the January 2015 MDF Note provides for a third installment of $500,000, payable on January 1, 2016.  The January 2015 Variable Notes, which secure the advances, mature on December 31, 2017 and bear interest only upon the occurrence of an event of default, as defined in each of the January 2015 Variable Notes.  All amounts outstanding, including interest, are due on the maturity date, subject to acceleration upon the occurrence of an event of default.
	Under the January 2015 Production Note, the Distributor is eligible to earn bonus commissions for each qualifying sale of our products, as defined in the January 2015 Production Note. Any such bonus commissions earned during the term of the January 2015 Production Note will be applied against the outstanding balance payable to us under the January 2015 Production Note, in lieu of a cash payment to us, and the net amount (if any) will be payable to the Distributor.
	Under the January 2015 MDF Note, the Distributor is eligible to earn production credits for achieving certain sales targets of our products, as defined in the January 2015 MDF Note.  Any such production credits earned during the term of the January 2015 MDF Note will be applied against the outstanding balance payable to us under the January 2015 MDF Note, in lieu of a cash payment to us, but no amount will be payable to us by the Distributor.
	Of these advances, balances that will be realized within twelve months are included in advanced commissions, and the portions not realizable within twelve months are included in other long-term assets on the accompanying condensed consolidated balance sheets.  The balances in the current and other long-term assets were $1.6 million and $875,000 as of March 31, 2015.
	In addition, in January 2015 we entered into a revolving secured promissory note (the “January 2015 Revolver”) with the Distributor.  Pursuant to the January 2015 Revolver, we may make loans, from time to time, to the Distributor.  The maximum aggregate principal amount loaned by us under the January 2015 Revolver  is capped at the lesser of what we refer to as the available amount and $1,000,000 (increased to $1,500,000 on July 1, 2015 if there has not been an event of default, as defined in the January 2015 Revolver).  The January 2015 Revolver bears interest at an annual rate of 6.0%.  Pursuant to the January 2015 Revolver, on each of December 31, 2015 and 2016, the Distributor shall make a payment to us in an amount that will reduce the amount outstanding under the January 2015 Revolver to $300,000 or less plus accrued interest on the principal amounts so repaid.  The January 2015 Revolver matures on December 31, 2017.  All amounts outstanding, including interest, are due on the maturity date, subject to acceleration upon the occurrence of an event of default. In January 2015, we loaned $1.0 million to the Distributor under the January 2015 Revolver.  During the three months ended March 31, 2015, we accrued $13,000 in interest on the note.  The note is included in note receivable on the accompanying condensed consolidated balance sheet.
	Legal Proceedings
	As of March 31, 2015, we had no significant outstanding legal proceedings. We are subject to certain legal proceedings and claims that may arise in the ordinary course of business. In the opinion of management, we do not have a potential liability related to any current legal proceedings and claims that would individually, or in the aggregate, have a material adverse effect on our financial condition, liquidity, results of operations, or cash flows.

Fair_Value_Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2015
Fair Value Disclosures [Abstract]
Fair Value Measurements	11. Fair Value Measurements
	We measure and report financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (referred to as an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value of our financial assets and liabilities is determined by using three levels of input, which are defined as follows:
	Level 1:	Quoted prices in active markets for identical assets or liabilities
	Level 2:	Quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability
	Level 3:	Unobservable inputs for the asset or liability
	The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
	We utilize the market approach to measure the fair value of our financial assets. As subjectivity exists with respect to many of the valuation techniques, the fair value estimates we have disclosed may not equal prices that we may ultimately realize if the assets are sold or the liabilities are settled with third parties. Below is a description of our valuation methods.
	Investments. Our short-term investments include certificates of deposit. The certificates of deposit have maturities ranging from greater than three to fifteen months. The investments are classified within Level 1 of the fair value hierarchy. Because the carrying values of the investments approximate the fair values, there are no holding gains or losses on these securities.
	Contingent consideration for business acquisition. The contingent consideration related to the acquisition of Secured and ASIA includes periodic cash payments, as described in Note 2, and are valued using external valuation specialists. The inputs include discount rates reflecting the credit risk, and the probability of the underlying outcome of the results required by Secured to receive payment and the nature of such payments. The underlying outcomes are subject to the target results in the respective instruments or agreement. These liabilities are included in Level 3 of the fair value hierarchy.
	Noncompete obligation. Our noncompete obligation, an exclusivity agreement with the developer of the A.R.I.E.S System as described in Note 10 is primarily valued using nonbinding market prices as stated in the agreement that are corroborated by observable market data. The inputs and fair value are reviewed for reasonableness and may be further validated by comparison to publicly available information or compared to multiple independent valuation sources. The noncompete obligation is classified within Level 2 of the fair value hierarchy.
	The carrying amounts of financial assets and liabilities reported in the accompanying consolidated balance sheets for cash and cash equivalents, cash held on behalf of others, credit card transactions receivable, accounts receivable, advanced commissions, carriers and vendors payable, commissions payable, and accounts payable and accrued expenses as of March 31, 2015 and December 31, 2014, respectively, approximate fair value because of the short-term duration of these instruments.
	As of March 31, 2015, our assets and liabilities measured at fair value were as follows ($ in thousands):
					Fair Value Measurement as of March 31, 2015
		Carrying Value as of March 31, 2015			Level 1		Level 2		Level 3
	Liabilities:
	Noncompete obligation	$	421		$	—	$	418	$	—
	Contingent acquisition consideration		3,459			—		—		3,459
		$	3,880		$	—	$	418	$	3,459
	As of December 31, 2014, our assets and liabilities measured at fair value were as follows ($ in thousands):
					Fair Value Measurement as of December 31, 2013
		Carrying Value as of December 31, 2014			Level 1		Level 2		Level 3
	Assets:
	Certificates of deposit	$	461		$	461	$	—	$	—
	Liabilities:
	Noncompete obligation	$	463		$	—	$	457	$	—
	Contingent acquisition consideration		4,400			—		—		4,400
		$	4,863		$	—	$	457	$	4,400
	A summary of the changes in the fair value of liabilities carried at fair value that have been classified in Level 3 of the fair value hierarchy was as follows ($ in thousands):
		Contingent Acquisition Consideration
	Balance as of January 1, 2014	$	3,876
	Issuance and settlements, net		(579	)
	Loss included in income		1,103
	Balance as of January 1, 2015		4,400
	Issuance and settlements, net		(450	)
	Gain included in income		(491	)
	Balance as of January 1, 2015	$	3,459
	Gain or loss on the contingent acquisition are included in other (income) expense on the accompanying condensed consolidated statements of operations.

Segments

Segments	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Segments	12. Segments
	For the three months ended March 31, 2015, we operated as two reportable segments: 1) Insurance Plan Development and Distribution (“IPD”) and 2) HP. For the three months ended March 31, 2014, we operated as a single reportable segment, IPD. The IPD segment comprises our business activities in designing, implementing and administering STM and other products and the distribution of those products to consumers via our call center distribution network and online purchasing. The HP segment comprises the business activities of HP, including the development of HealthPocket.com and generation of referral-based and other revenues. Intercompany revenues are based on contracted rates for services provided, which generally are referrals provided by HP to IPD.
	The following table shows the financial results of our operating segments for the three months ended March 31, 2015 ($ in thousands). For the three months ended March 31, 2014, we operated as a single reportable segment.
		IPD			HP			Inter-Segment Eliminations			Consolidated Total
	Revenues	$	22,112		$	664		$	(235	)	$	22,541
	Other operating expenses		21,413			1,305			(235	)		22,483
	Depreciation and amortization		464			320			—			784
	Total operating expenses		21,877			1,625			(235	)		23,267
	Other income		(646	)		—			—			(646	)
	Net income (loss) before income taxes		881			(961	)		—			(80	)
	Provision (benefit) for income taxes		54			(390	)		—			(336	)
	Net income (loss)		827			(571	)		—			256
	Total assets as of March 31, 2015	$	53,198		$	29,953		$	(735	)	$	82,416

Related_Party_Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2015
Related Party Transactions [Abstract]
Related Party Transactions	13. Related Party Transactions
	Health Plan Intermediaries, LLC
	HPI and its subsidiary HPIS, which are beneficially owned by Mr. Kosloske, are related parties by virtue of their Series B Membership Interests in HPIH, of which we are managing member. During the three months ended March 31, 2015 and 2014, HPIH paid cash distributions of $319,000 and $921,000, respectively, to these entities related to estimated federal and state income taxes, pursuant to the operating agreement entered into by HPIH and HPI.
	Tax Receivable Agreement
	As discussed in Note 10, on February 13, 2013, we entered into a TRA with the holders of the HPIH Series B Membership Interests, which holders are beneficially owned by Mr. Kosloske.
	As of March 31, 2015, we have made no such payments under the TRA. As of March 31, 2015, we would be obligated to pay $741,000 pursuant to the TRA, of which $229,000 is included in current liabilities and $512,000 is included in long-term liabilities on the accompanying condensed consolidated balance sheets. As of December 31, 2014, $$616,000 was payable pursuant to the TRA, and $229,000 and $387,000 were included in short-term liabilities and long-term liabilities, respectively in our accompanying condensed consolidated balance sheets.  Our total liability pursuant to the TRA for exchange transactions completed through March 31, 2015 would be $10.8 million if we generate sufficient taxable income in the future.
	Health Benefits One, LLC
	In October 2013, HPIH formed SIL with HBO, one of our distributors. In March 2015, HPIH sold its interest in SIL to HBO. See Note 3 for more information on this joint venture. HBO was a related party by virtue of its 50% ownership of membership interests in SIL. During the three months ended March 31, 2015 and 2014, we made net advanced commissions payments of $1.1 million and $454,000, respectively, and recognized $3.0 million and $867,000, respectively, of commission expense related to HBO. As of March 31, 2015 and December 31, 2014, the advanced commissions balances related to HBO included in the accompanying condensed consolidated balance sheets were $3.4 million and $2.3 million, respectively.
	TSG Agency, LLC
	TSG Agency, LLC (“TSG”) was a related party by virtue of its involvement in ICE. On March 14, 2013, we terminated our contract rights with TSG for an aggregate cash price of $5.5 million. In conjunction with the transaction, Ivan Spinner, TSG’s principal, joined HII as an employee.
	On March 15, 2014, Mr. Spinner’s employment agreement with HII was terminated.

Subsequent_Events

Subsequent Events	3 Months Ended
	Mar. 31, 2015
Subsequent Events [Abstract]
Subsequent Events	14.  Subsequent Events
	Distributor Commission Advance
	On May 1, 2015, we entered into an agreement with HBO, and certain individuals and entities related to HBO to make advances via a variable secured promissory note (the “May 2015 Note”). The May 2015 Note provides for two advances of $500,000 each.  The May 2015 Note, which secures the advances, matures on January 31, 2017 and bears an interest only upon the occurrence of an event of default, as defined in the May 2015 Note.  All amounts outstanding, including interest, are due within thirty days of the maturity date, subject to acceleration upon the occurrence of an event of default.
	Under the May 2015 Note, HBO is eligible to earn production credits, beginning in January 2016, for each qualifying sale of our products, as defined in the May 2015 Note. Such production credits will be applied based on qualifying sales during each calendar quarter of 2016.  Any such production credits earned during calendar year 2016 will be applied against the outstanding balance payable to us under the May 2015 Note, in lieu of a cash payment to us, but no amount will be payable by us to HBO.
	Modification of Secured Contingent Consideration
	On May 5, 2015, we entered into an agreement to modify the contingent acquisition consideration of agreement with Secured.  See Note 2 for further information on the contingent acquisition consideration agreement.
	Pursuant to this modification, the remaining maximum payout under the existing contingent consideration terms allocable to Mr. Joseph Safina, one of the former owners of Secured, was paid in a lump-sum of $973,000 on May 7, 2015.  The remaining maximum payouts allocable to Mr. Howard Knaster and Mr. Jorge Saavedra, the other two former owners of Secured, will be paid ratably over 14 months, beginning on May 29, 2015.

Organization_Basis_of_Presenta1

Organization, Basis of Presentation and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2015
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation
	The condensed consolidated financial statements reflect the accounts of the Company. Intercompany accounts and transactions have been eliminated in consolidation.
	Noncontrolling interests are included in the consolidated balance sheets as a component of stockholders’ equity that is not attributable to the equity of the Company. We report separately the amounts of consolidated net loss or income attributable to us and noncontrolling interests.
	As an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), we benefit from certain temporary exemptions from various reporting requirements, including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act and reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements. We have also elected under the JOBS Act to delay the adoption of new and revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies.  As a result of this election, our financial statements may not be comparable to companies that comply with public company effective dates. These exemptions will apply for a period of five years following the completion of our IPO. However, if the market value of our common stock that is held by non-affiliates exceeds $700 million as of any June 30 before that time, we would cease to be an emerging growth company as of the following December 31.
	The information included in this quarterly report, including the interim condensed consolidated financial statements and the accompanying notes, should be read in conjunction with the audited consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014.
Reclassifications	Reclassifications
	Certain amounts in the prior period’s consolidated financial statements have been reclassified to conform to the current period presentation. Such reclassifications include excluding amounts payable for third-party commission expense from cash held on behalf of others and including such amounts in cash and cash equivalents in the accompanying condensed consolidated balance sheets and statements of cash flows, and fair value adjustment for contingent consideration as a separate component in the accompanying consolidated statements of operations, as compared to a component of other income (expense) in the prior period.
Use of Estimates	Use of Estimates
	The accompanying unaudited interim condensed consolidated financial statements of the Company include all normal recurring accruals and adjustments considered necessary by management for their fair presentation in conformity with accounting principles generally accepted in the United States of America (“GAAP”). Preparing financial statements in accordance with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates. The consolidated results of operations for the three months ended March 31, 2015 are not necessarily indicative of results that may be expected for the year ending December 31, 2015 or any future interim period.
Website Development Costs	Property and equipment, net
	Included in property and equipment, net are website development costs. These costs incurred in the development of websites are either expensed as incurred or capitalized depending on the nature of the cost and the stage of development of the project under which a website or websites are developed.  Generally, the costs incurred during the planning stage are expensed as incurred; the costs incurred for activities during the website application and infrastructure development stage are capitalized; costs incurred during the graphics development stage are capitalized if such costs are for the creation of initial graphics for the website; subsequent updates to the initial graphics are expensed as incurred, unless they provide additional functionality; costs incurred during the content development stage are expensed as incurred unless they are for the integration of a database with the website, which are capitalized; and, the costs incurred during the operating stage are expensed as incurred.
	Upon reaching the operating phase of the website application and infrastructure phase, the capitalized costs are amortized over the estimated useful life of the capitalized costs, which we expect to be five years.
	During the three months ended March 31, 2015, we capitalized $493,000 of costs incurred in the development of a website for which the software underlying the website will not be marketed externally.  This balance is included in property and equipment, net on the accompanying condensed consolidated balance sheets.  Substantially all of the costs incurred during the period were part of the website application phase, and as of March 31, 2015, the operating phase of the website has not commenced.  As such, no amortization has been recorded on the capitalized website development costs.
Recent Accounting Pronouncements	Recent Accounting Pronouncements
	In the following summary of recent accounting pronouncements, all references to effective dates of Financial Accounting Standards Board (“FASB”) guidance relate to nonpublic entities. As noted above, we have elected to delay the adoption of new and revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies under provisions of the JOBS Act.
	In February 2015, the FASB issued an amendment to its accounting guidance related to financial statement consolidation.  This guidance affects reporting entities that are required to evaluate whether they should consolidate certain legal entities. Specifically, it modifies the evaluation of whether limited partnerships and similar legal entities are variable interest entities (“VIEs”) or voting interest entities, eliminates the presumption that a general partner should consolidate a limited partnership and affects the consolidation analysis of reporting entities that are involved with certain VIEs. This guidance is effective for fiscal years beginning after December 15, 2016. Early adoption is permitted. We are currently evaluating the impact of this guidance on our condensed consolidated financial statements.
	In May 2014, the FASB issued an amendment to its accounting guidance related to revenue recognition. The amendment clarifies the principles for recognizing revenue. The guidance is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in the judgments and assets recognized from costs incurred to obtain or fulfill a contract. We will adopt this guidance in reporting periods beginning after December 15, 2017. We are currently evaluating the impact of adopting this pronouncement on our consolidated financial statements.
	In April 2014, the FASB issued guidance related to discontinued operations reporting.  The new guidance changes the definition and reporting of discontinued operations to include only those disposals that represent a strategic shift and that have a major effect on an entity's operations and financial results. The new guidance, which also requires additional disclosures, becomes effective for annual periods beginning on or after December 15, 2015 and interim periods within those years and allows for early adoption.  We adopted this guidance as of January 1, 2015, and as a result determined that our disposition of our interest in SIL, which is described in Note 3, was not a strategic shift in, nor did it have a major effect on our operations or financial results.  As such, we did not treat SIL as a discontinued operation in our condensed consolidated financial statements.

Business_Acquisitions_Tables

Business Acquisitions (Tables)	3 Months Ended
	Mar. 31, 2015
HealthPocket, Inc
Summary of Fair Value of Consideration for Acquisition	The following table summarizes the fair value of the consideration for the acquisition as of July 14, 2014 ($ in thousands):
	Cash paid at closing (1)	$	21,901
	Class A common stock, at fair value (2)		6,734
	Total consideration	$	28,635
	-1	Cash paid at closing includes $17.0 million in cash, $3.2 million in cash held in escrow, as noted above, $1.2 million for the payoff of outstanding bank debt held by HP, $54,000 for the payoff of HP loans payable to Telkamp and Wang, and $482,000 in estimated acquisition-related expenses incurred by HP.
	-2	The fair value of the Class A common stock derived from the market price of the stock, adjusted to include a discount for a lack of marketability, due to trading restrictions pursuant to the Merger Agreement and other factors.
Summary of Allocation of Total Purchase Prices of Acquisition	The following table summarizes the allocation of the total purchase price for the acquisition as of July 14, 2014 ($ in thousands):
	Cash	$	1,294
	Accounts receivable and other assets (1)		104
	Property and equipment (1)		6
	Accounts payable, accrued expenses and other liabilities (1)		(480	)
	Deferred tax liability – long-term		(2,967	)
	Intangible asset – technology		8,000
	Intangible asset – brand		1,280
	Intangible asset – customer relationships		430
	Intangible asset – noncompete agreements		27
	Goodwill (2)		20,941
		$	28,635
	-1	The carrying value of accounts receivable, accounts payable, accrued expenses and property and equipment approximated fair value; as such, no adjustments to the accounts were recorded in association with the acquisition.
	-2	As of March 31, 2015, we expect none of the goodwill acquired in this transaction to be deductible for income tax purposes.
American Service Insurance Agency, LLC
Summary of Fair Value of Consideration for Acquisition	The following table summarizes the fair value of the consideration for the acquisition as of August 8, 2014 ($ in thousands):
	Cash paid at closing	$	1,825
	Contingent consideration, at fair value		1,263
	Total consideration	$	3,088
Summary of Allocation of Total Purchase Prices of Acquisition	The following table summarizes the allocation of the total purchase price for the acquisition as of August 8, 2014 ($ in thousands):
	Cash	$	105
	Accounts receivable and other assets (1)		271
	Accounts payable, accrued expenses and other liabilities  (1)		(163	)
	Intangible asset – customer relationships – distributors		449
	Intangible asset – customer relationships – direct		266
	Intangible asset – brand		21
	Intangible asset – noncompete agreements		18
	Goodwill (2)		2,121
		$	3,088
	-1	The carrying value of accounts receivable, accounts payable, accrued expenses and property and equipment approximated fair value; as such, no adjustments to the accounts were recorded in association with the acquisition.
	-2	As of March 31, 2015, the amount of goodwill acquired that we expect to be deductible for income tax purposes is $840,000.

Goodwill_and_Intangible_Assets1

Goodwill and Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2015
Goodwill And Intangible Assets Disclosure [Abstract]
Summary of Changes in Carrying Amounts of Goodwill by Operating Segment	The changes in the carrying amounts of goodwill by operating segment are as follows ($ in thousands):
		IPD		HP			Total
	Balance as of January 1, 2014	$	18,014	$	-		$	18,014
	Goodwill acquired		2,121		20,941			23,062
	Impairment of goodwill		—		—			—
	Balance as of December 31, 2014		20,135		20,941			41,076
	Goodwill acquired		—		—			—
	Impairment of goodwill		—		—			—
	Balance as of March 31, 2015	$	20,135	$	20,941		$	41,076
Schedule of Major Classes of Intangible Assets	Major classes of intangible assets as of March 31, 2015 consisted of the following ($ in thousands):
		Weighted-average Amortization (years)			Gross Carrying Amount				Accumulated Amortization			Intangible Assets, net
	Brand		14.1		$	1,377			$	(136	)	$	1,241
	Carrier network		5			40				(28	)		12
	Distributor relationships		9.3			5,109				(1,945	)		3,164
	Noncompete agreements		4.7			987				(517	)		470
	Customer relationships		5.8			1,484				(783	)		701
	Capitalized software		6.7			8,571				(1,330	)		7,241
	Total intangible assets		7.8		$	17,568			$	(4,739	)	$	12,829
	Major classes of intangible assets as of December 31, 2014 consisted of the following ($ in thousands):
		Weighted-average Amortization (years)			Gross Carrying Amount				Accumulated Amortization			Intangible Assets, net
	Brand		14.1		$	1,377			$	(103	)	$	1,274
	Carrier network		5			40				(26	)		14
	Distributor relationships		9.3			5,109				(1,791	)		3,318
	Noncompete agreements		4.7			987				(462	)		525
	Customer relationship		5.8			1,484				(644	)		840
	Capitalized software		6.7			8,571				(977	)		7,594
	Total intangible assets		7.8		$	17,568			$	(4,003	)	$	13,565
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
	Estimated annual pretax amortization of intangible assets for the remainder of 2015 and in each of the next five years are as follows ($ in thousands):
	Remainder of 2015	$	1,907
	2016		2,173
	2017		1,984
	2018		1,743
	2019		1,357
	2020		1,357
	Thereafter		2,308
	Total	$	12,829

Accounts_Payable_and_Other_Lia1

Accounts Payable and Other Liabilities (Tables)	3 Months Ended
	Mar. 31, 2015
Payables And Accruals [Abstract]
Summary of Accounts Payable and Accrued Expenses	Accounts payable and accrued expenses consisted of the following as of ($ in thousands):
		31-Mar-15		31-Dec-14
	Accounts payable	$	594	$	906
	Carriers and vendors payable		4,766		5,830
	Commissions payable		1,704		2,009
	Accrued wages		646		1,062
	Accrued refunds		708		815
	Accrued credit card/ACH fees		127		144
	Accrued interest		-		1
	Accrued professional fees		259		198
	Other accruals		526		432
	Total accounts payable and accrued expenses	$	9,330	$	11,397

Stockholders_Equity_Tables

Stockholders' Equity (Tables)	3 Months Ended
	Mar. 31, 2015
Stockholders Equity Note [Abstract]
Effects of Changes in Ownership Interests in Equity	The following table presents the effects of changes in HII’s ownership interests in HPIH and its consolidated subsidiaries on its equity ($ in 000’s):
		Three months ended March 31,
		2015			2014
	Net income (loss) attributable to Health Insurance Innovations, Inc.	$	53		$	(74	)
	Distributions		(319	)		(5	)
	Total	$	(266	)	$	(79	)

Stockbased_Compensation_Tables

Stock-based Compensation (Tables)	3 Months Ended
	Mar. 31, 2015
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Summary of Weighted Average Assumptions	The Black-Scholes option-pricing model was used with the following weighted average assumptions:
		Three months ended
		March 31,
		2015			2014
	Risk-free interest rate		1.6	%		1.2	%
	Expected life	4.9 years			4.7 years
	Expected volatility		40.7	%		44	%
	Expected dividend yield	none			none
Summary of SARs and Restricted Shares Granted	The following table summarizes restricted shares, SARs, and stock options granted during the three months ended March 31, 2015 and 2014 (in thousands):
		Three months ended
		March 31,
		2015			2014
	SARs issued		—			—
	Restricted shares issued		10			—
	Stock options issued		—			—
Summary of Stock Based Compensation Expense	The following table summarizes stock-based compensation expense for the three months ended March 31, 2015 and 2014 ($ in thousands):
		Three months ended
		March 31,
		2015			2014
	SARs	$	(4	)	$	203
	Restricted shares		(66	)		202
	Stock options		131			—
		$	61		$	405
Summary of Unrecognized Stock Based Compensation	The following table summarizes unrecognized stock-based compensation and the remaining weighted average period over which such stock-based compensation is expected to be recognized as of March 31, 2015 ($ in thousands):
					Weighted Average Remaining years
	SARs	$	650			2.1
	Restricted shares		688			1.9
	Stock options		338			1.3
		$	1,676

Net_Income_Loss_per_Share_Tabl

Net Income (Loss) per Share (Tables)	3 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Summary of Reconciliation of Numerators and Denominators of Basic and Diluted Net Income (Loss)	The computations of basic and diluted net income (loss) per share attributable to HII for the three months ended March 31, 2015 and 2014 were as follows ($ in thousands, except share and per share data):
		Three months ended March 31,
		2015		2014
	Basic net income (loss) attributable to Health Insurance Innovations, Inc.	$	53	$	(74	)
	Average shares—basic		7,515,053		5,025,669
	Effect of dilutive securities:
	Restricted shares		181,928		—
	Stock options		17,358		—
	Average shares—diluted		7,714,339		5,025,669
	Basic net income (loss) per share attributable to Health Insurance Innovations, Inc.	$	0.01	$	(0.01	)
	Diluted net income (loss) per share attributable to Health Insurance Innovations, Inc.	$	0.01	$	(0.01	)
Summary of Securities Not Included in Calculation of Diluted Net Income (Loss)	The following securities were not included in the calculation of diluted net income (loss) per share because such inclusion would be anti-dilutive (in thousands):
		Three months ended March 31,
		2015		2014
	Restricted shares		14		130
	SARs		419		359
	Stock options		23		—

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2015
Fair Value Disclosures [Abstract]
Summary of Assets and Liabilities Measured at Fair Value	As of March 31, 2015, our assets and liabilities measured at fair value were as follows ($ in thousands):
					Fair Value Measurement as of March 31, 2015
		Carrying Value as of March 31, 2015			Level 1		Level 2		Level 3
	Liabilities:
	Noncompete obligation	$	421		$	—	$	418	$	—
	Contingent acquisition consideration		3,459			—		—		3,459
		$	3,880		$	—	$	418	$	3,459
	As of December 31, 2014, our assets and liabilities measured at fair value were as follows ($ in thousands):
					Fair Value Measurement as of December 31, 2013
		Carrying Value as of December 31, 2014			Level 1		Level 2		Level 3
	Assets:
	Certificates of deposit	$	461		$	461	$	—	$	—
	Liabilities:
	Noncompete obligation	$	463		$	—	$	457	$	—
	Contingent acquisition consideration		4,400			—		—		4,400
		$	4,863		$	—	$	457	$	4,400
Summary of the Changes in the Fair Value of Liabilities Carried at Fair Value	A summary of the changes in the fair value of liabilities carried at fair value that have been classified in Level 3 of the fair value hierarchy was as follows ($ in thousands):
		Contingent Acquisition Consideration
	Balance as of January 1, 2014	$	3,876
	Issuance and settlements, net		(579	)
	Loss included in income		1,103
	Balance as of January 1, 2015		4,400
	Issuance and settlements, net		(450	)
	Gain included in income		(491	)
	Balance as of January 1, 2015	$	3,459

Segments_Tables

Segments (Tables)	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Schedule of Financial Results of Reportable Segments
	The following table shows the financial results of our operating segments for the three months ended March 31, 2015 ($ in thousands). For the three months ended March 31, 2014, we operated as a single reportable segment.
		IPD			HP			Inter-Segment Eliminations			Consolidated Total
	Revenues	$	22,112		$	664		$	(235	)	$	22,541
	Other operating expenses		21,413			1,305			(235	)		22,483
	Depreciation and amortization		464			320			—			784
	Total operating expenses		21,877			1,625			(235	)		23,267
	Other income		(646	)		—			—			(646	)
	Net income (loss) before income taxes		881			(961	)		—			(80	)
	Provision (benefit) for income taxes		54			(390	)		—			(336	)
	Net income (loss)		827			(571	)		—			256
	Total assets as of March 31, 2015	$	53,198		$	29,953		$	(735	)	$	82,416

Organization_Basis_of_Presenta2

Organization, Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)	3 Months Ended	0 Months Ended
	Mar. 31, 2015	Mar. 31, 2015
Organization Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Period of exemptions under JOBS Act	5 years
Market value of common stock held by non-affiliates	$700,000,000
Capitalized website development costs	493,000
Amortization of capitalized website development costs	$0
Health Plan Intermediaries Holdings, LLC
Organization Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Percentage of voting interests		100.00%
Variable interest entity | Health Plan Intermediaries Holdings, LLC
Organization Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Percentage of voting interests	100.00%

Business_Acquisitions_Addition

Business Acquisitions - Additional Information (Detail) (USD $)	3 Months Ended		12 Months Ended	0 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Jul. 14, 2014		Aug. 08, 2014
Business Acquisition [Line Items]
Common stock issued as acquisition consideration			$6,734,000
Revenue	22,541,000	17,927,000
Pre-tax net loss	-726,000	367,000
Amortization expense	736,000	375,000
Fair value adjustment to contingent acquisition consideration	-491,000	722,000
Class A common stock
Business Acquisition [Line Items]
Common stock issued as acquisition consideration, shares			815,991
Common stock, par value	$0.00		$0.00
Common stock issued as acquisition consideration			1,000
HealthPocket, Inc
Business Acquisition [Line Items]
Date of merger agreement with HealthPocket, Inc	14-Jul-14
Cash paid at closing				21,901,000	[1]
Common stock issued as acquisition consideration, shares	815,991
Merger consideration deposited as escrow deposit				3,200,000
Percentage of shares former equity holders will take in cash or stock				50.00%
Noncompetition covenant expiration date	14-Jul-17
Revenue	664,000
Pre-tax net loss	961,000
Amortization expense	316,000
HealthPocket, Inc | Replacement Options
Business Acquisition [Line Items]
Total number of replacement Options				84,909
HealthPocket, Inc | Class A common stock
Business Acquisition [Line Items]
Common stock issued as acquisition consideration, shares				900,900
Common stock, par value				$0.00
Common stock issued as acquisition consideration				10,000,000
Price per share of shares issued for acquisition				$11.10
HealthPocket, Inc | Fair Value | Class A common stock
Business Acquisition [Line Items]
Class A common stock, at fair value				6,734,000	[2]
American Service Insurance Agency, LLC
Business Acquisition [Line Items]
Cash paid at closing						1,825,000
Revenue	921,000
Pre-tax net loss	285,000
Amortization expense	45,000
Contingent acquisition consideration	500,000					2,200,000
Potential total contingent consideration, minimum						0
Potential total contingent consideration, maximum						2,200,000
Fair value adjustment to contingent acquisition consideration	529,000
Date of employment agreement with Jordan	8-Aug-14
Expiration date of Agreement	8-Aug-17
Employment contract termination period						1 year
American Service Insurance Agency, LLC | Initial payment
Business Acquisition [Line Items]
Cash paid at closing						1,800,000
American Service Insurance Agency, LLC | Paid at closing
Business Acquisition [Line Items]
Cash paid at closing						1,500,000
Merger consideration prior deposit amount						325,000
American Service Insurance Agency, LLC | First Potential Cash Payment
Business Acquisition [Line Items]
Contingent acquisition consideration						1,200,000
American Service Insurance Agency, LLC | Second Potential Cash Payment
Business Acquisition [Line Items]
Contingent acquisition consideration						1,000,000
American Service Insurance Agency, LLC | Fair Value
Business Acquisition [Line Items]
Contingent acquisition consideration	$864,000
[1]	Cash paid at closing includes $17.0 million in cash, $3.2 million in cash held in escrow, as noted above, $1.2 million for the payoff of outstanding bank debt held by HP, $54,000 for the payoff of HP loans payable to Telkamp and Wang, and $482,000 in estimated acquisition-related expenses incurred by HP.
[2]	The fair value of the Class A common stock derived from the market price of the stock, adjusted to include a discount for a lack of marketability, due to trading restrictions pursuant to the Merger Agreement and other factors.

Business_Acquisitions_Summary_

Business Acquisitions - Summary of Fair Value of Consideration for Acquisition (Detail) (USD $)	0 Months Ended
In Thousands, unless otherwise specified	Jul. 14, 2014		Aug. 08, 2014
HealthPocket, Inc
Business Acquisition [Line Items]
Cash paid at closing	$21,901	[1]
Total consideration	28,635
HealthPocket, Inc | Fair Value | Class A common stock
Business Acquisition [Line Items]
Class A common stock, at fair value	6,734	[2]
American Service Insurance Agency, LLC
Business Acquisition [Line Items]
Cash paid at closing			1,825
Total consideration			3,088
American Service Insurance Agency, LLC | Fair Value
Business Acquisition [Line Items]
Contingent consideration			$1,263
[1]	Cash paid at closing includes $17.0 million in cash, $3.2 million in cash held in escrow, as noted above, $1.2 million for the payoff of outstanding bank debt held by HP, $54,000 for the payoff of HP loans payable to Telkamp and Wang, and $482,000 in estimated acquisition-related expenses incurred by HP.
[2]	The fair value of the Class A common stock derived from the market price of the stock, adjusted to include a discount for a lack of marketability, due to trading restrictions pursuant to the Merger Agreement and other factors.

Business_Acquisitions_Summary_1

Business Acquisitions - Summary of Fair Value of Consideration for Acquisition (Parenthetical) (Detail) (HealthPocket, Inc, USD $)	0 Months Ended
	Jul. 14, 2014
Business Acquisition [Line Items]
Business acquisition consideration cash payment	$17,000,000
Merger consideration deposited as escrow deposit	3,200,000
Acquisition related expenses	482,000
Loans payable to Telkamp and Wang
Business Acquisition [Line Items]
Contingent consideration	54,000
Outstanding bank debt
Business Acquisition [Line Items]
Contingent consideration	$1,200,000

Business_Acquisitions_Summary_2

Business Acquisitions - Summary of Allocation of Total Purchase Prices for Acquisition (Detail) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Jul. 14, 2014		Aug. 08, 2014
In Thousands, unless otherwise specified
Business Acquisition [Line Items]
Goodwill	$41,076	$41,076	$18,014
HealthPocket, Inc
Business Acquisition [Line Items]
Cash				1,294
Accounts receivable and other assets				104	[1]
Property and equipment				6	[1]
Accounts payable and accrued expenses				-480	[1]
Deferred tax liability b long-term				-2,967
Goodwill				20,941	[2]
Total consideration				28,635
HealthPocket, Inc | Technology
Business Acquisition [Line Items]
Intangible asset				8,000
HealthPocket, Inc | Brand
Business Acquisition [Line Items]
Intangible asset				1,280
HealthPocket, Inc | Customer relationships
Business Acquisition [Line Items]
Intangible asset				430
HealthPocket, Inc | Noncompete agreements
Business Acquisition [Line Items]
Intangible asset				27
American Service Insurance Agency, LLC
Business Acquisition [Line Items]
Cash						105
Accounts receivable and other assets						271	[1]
Goodwill						2,121	[3]
Total consideration						3,088
Accounts payable, accrued expenses and other liabilities						-163	[1]
American Service Insurance Agency, LLC | Brand
Business Acquisition [Line Items]
Intangible asset						21
American Service Insurance Agency, LLC | Noncompete agreements
Business Acquisition [Line Items]
Intangible asset						18
American Service Insurance Agency, LLC | Customer Relationships-Distributors
Business Acquisition [Line Items]
Intangible asset						449
American Service Insurance Agency, LLC | Customer Relationships-Direct
Business Acquisition [Line Items]
Intangible asset						$266
[1]	The carrying value of accounts receivable, accounts payable, accrued expenses and property and equipment approximated fair value; as such, no adjustments to the accounts were recorded in association with the acquisition.
[2]	As of March 31, 2015, we expect none of the goodwill acquired in this transaction to be deductible for income tax purposes.
[3]	As of March 31, 2015, the amount of goodwill acquired that we expect to be deductible for income tax purposes is $840,000

Business_Acquisitions_Summary_3

Business Acquisitions - Summary of Allocation of Total Purchase Prices for Acquisition (Parenthetical) (Detail) (USD $)	Mar. 31, 2015
HealthPocket, Inc
Business Acquisition [Line Items]
Business acquisition, goodwill, expected tax deductible amount	$0
American Service Insurance Agency, LLC
Business Acquisition [Line Items]
Business acquisition, goodwill, expected tax deductible amount	$840,000

Variable_Interest_Entities_Add

Variable Interest Entities - Additional Information (Detail) (USD $)	0 Months Ended	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2015	Dec. 31, 2014	Mar. 23, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2013	Oct. 07, 2013
Variable Interest Entity [Line Items]
Advanced commissions	8,022,000	$8,022,000	$5,973,000
Health Benefits One L L C
Variable Interest Entity [Line Items]
Advanced commissions				246,000
Health Benefits One L L C | Scenario, Forecast
Variable Interest Entity [Line Items]
Contingent consideration receivable, percentage					10.00%	10.00%
Health Plan Intermediaries Holdings, LLC
Variable Interest Entity [Line Items]
Percentage of voting interests	100.00%
Total membership interest without voting right	52.80%	52.80%
Simple Insurance Leads LLC
Variable Interest Entity [Line Items]
Capital contribution							492,000
Variable interest entity beneficiary agreement loan							185,000
Variable interest entity maximum loss exposure of contributed capital, percentage								100.00%
Simple Insurance Leads LLC | Unit Purchase Agreement
Variable Interest Entity [Line Items]
Gain on deconsolidation of variable interest entity		$189,000

Goodwill_and_Intangible_Assets2

Goodwill and Intangible Assets - Summary of Changes in Carrying Amounts of Goodwill by Operating Segment (Detail) (USD $)	3 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Goodwill [Line Items]
Goodwill Beginning Balance	$41,076	$18,014
Goodwill acquired		23,062
Impairment loss on goodwill	0	0
Goodwill Ending Balance	41,076	41,076
Insurance Plan Development And Distribution
Goodwill [Line Items]
Goodwill Beginning Balance	20,135	18,014
Goodwill acquired		2,121
Impairment loss on goodwill	0	0
Goodwill Ending Balance	20,135	20,135
Health Pocket
Goodwill [Line Items]
Goodwill Beginning Balance	20,941
Goodwill acquired		20,941
Impairment loss on goodwill	0	0
Goodwill Ending Balance	$20,941	$20,941

Goodwill_and_Intangible_Assets3

Goodwill and Intangible Assets - Additional Information (Detail) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Goodwill And Intangible Assets Disclosure [Line Items]
Amortization expense	$736,000	$375,000
Minimum
Goodwill And Intangible Assets Disclosure [Line Items]
Finite lived intangible asset useful life	2 years
Maximum
Goodwill And Intangible Assets Disclosure [Line Items]
Finite lived intangible asset useful life	15 years

Goodwill_and_Intangible_Assets4

Goodwill and Intangible Assets - Schedule of Major Classes of Intangible Assets (Detail) (USD $)	3 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Acquired Finite Lived Intangible Assets [Line Items]
Weighted-average Amortization	7 years 9 months 18 days	7 years 9 months 18 days
Gross Carrying Amount	$17,568	$17,568
Accumulated Amortization	-4,739	-4,003
Intangible Asset, net	12,829	13,565
Brand
Acquired Finite Lived Intangible Assets [Line Items]
Weighted-average Amortization	14 years 1 month 6 days	14 years 1 month 6 days
Gross Carrying Amount	1,377	1,377
Accumulated Amortization	-136	-103
Intangible Asset, net	1,241	1,274
Carrier network
Acquired Finite Lived Intangible Assets [Line Items]
Weighted-average Amortization	5 years	5 years
Gross Carrying Amount	40	40
Accumulated Amortization	-28	-26
Intangible Asset, net	12	14
Distributor relationships
Acquired Finite Lived Intangible Assets [Line Items]
Weighted-average Amortization	9 years 3 months 18 days	9 years 3 months 18 days
Gross Carrying Amount	5,109	5,109
Accumulated Amortization	-1,945	-1,791
Intangible Asset, net	3,164	3,318
Noncompete agreements
Acquired Finite Lived Intangible Assets [Line Items]
Weighted-average Amortization	4 years 8 months 12 days	4 years 8 months 12 days
Gross Carrying Amount	987	987
Accumulated Amortization	-517	-462
Intangible Asset, net	470	525
Customer relationships
Acquired Finite Lived Intangible Assets [Line Items]
Weighted-average Amortization	5 years 9 months 18 days	5 years 9 months 18 days
Gross Carrying Amount	1,484	1,484
Accumulated Amortization	-783	-644
Intangible Asset, net	701	840
Capitalized software
Acquired Finite Lived Intangible Assets [Line Items]
Weighted-average Amortization	6 years 8 months 12 days	6 years 8 months 12 days
Gross Carrying Amount	8,571	8,571
Accumulated Amortization	-1,330	-977
Intangible Asset, net	$7,241	$7,594

Goodwill_and_Intangible_Assets5

Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Detail) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Goodwill And Intangible Assets Disclosure [Abstract]
Remainder of 2015	$1,907
2016	2,173
2017	1,984
2018	1,743
2019	1,357
2020	1,357
Thereafter	2,308
Intangible Asset, net	$12,829	$13,565

Accounts_Payable_and_Other_Lia2

Accounts Payable and Other Liabilities - Summary of Accounts Payable and Accrued Expenses (Detail) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Accounts payable and accrued expenses
Accounts payable	$594	$906
Carriers and vendors payable	4,766	5,830
Commissions payable	1,704	2,009
Accrued wages	646	1,062
Accrued refunds	708	815
Accrued credit card/ACH fees	127	144
Accrued interest		1
Accrued professional fees	259	198
Other accruals	526	432
Total accounts payable and accrued expenses	$9,330	$11,397

Stockholders_Equity_Additional

Stockholders' Equity - Additional Information (Detail) (USD $)	3 Months Ended	12 Months Ended	3 Months Ended	0 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Feb. 13, 2013	Dec. 17, 2014	Aug. 15, 2014	Feb. 01, 2014
Class Of Stock [Line Items]
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, par value	$0.00	0.001
Treasury stock, shares	269,729	47,144
Treasury Stock, Carrying Cost	$2,793	347
Repurchases of Class A common stock, shares	67,152
Treasury Stock Acquired, Average Cost Per Share	$7.17
Treasury Stock
Class Of Stock [Line Items]
Repurchases of Class A common stock, shares	67,152	43,318
Number of shares transferred to Treasury	5,433	12,403
Treasury Stock | Vested restricted stock awards
Class Of Stock [Line Items]
Number of shares transferred to Treasury	5,433		9,887
Treasury Stock | Forfeitures of restricted stock awards
Class Of Stock [Line Items]
Number of shares transferred to Treasury	150,000
Exchange Agreement
Class Of Stock [Line Items]
Issuance of common stock, shares	100,000
Issuance of common stock	1,400
HPI | Initial public offering
Class Of Stock [Line Items]
Issuance of common stock, shares				8,580,000
HPIS | Initial public offering
Class Of Stock [Line Items]
Issuance of common stock, shares				86,667
Class A common stock
Class Of Stock [Line Items]
Common stock, par value	$0.00	0.001
Common stock, shares authorized	100,000,000	100,000,000
Stock Repurchase Program Expiration Date					31-Dec-16
Repurchases of Class A common stock, shares	-67,152	-43,318
Number of shares transferred to Treasury	-5,433	-12,403
Class A common stock | Maximum
Class Of Stock [Line Items]
Stock Repurchase Program, Number of Shares Authorized to be Repurchased					800,000
Class A common stock | Underwriting Agreement
Class Of Stock [Line Items]
Issuance of common stock, shares						1,725,000
Share price						$11.54
Issuance of common stock						$19,900
Common stock price						$12.15
Class A common stock | HII
Class Of Stock [Line Items]
Common Stock, Voting Rights	one vote per share
Common stock voting rights percentage	52.80%
Economic interest	100.00%
Class A common stock | Initial public offering
Class Of Stock [Line Items]
Issuance of common stock, shares				4,666,667			8,566,667
Common stock, par value				0.001
Share price				14
Class B common stock
Class Of Stock [Line Items]
Common stock, par value	$0.00	0.001
Common stock, shares authorized	20,000,000	20,000,000
Class B common stock | HII
Class Of Stock [Line Items]
Common Stock, Voting Rights	one vote per share
Common stock voting rights percentage	47.20%
Economic interest	0.00%
Class B common stock | Initial public offering
Class Of Stock [Line Items]
Issuance of common stock, shares				8,666,667

Stockholders_Equity_Effects_of

Stockholders' Equity - Effects of Changes in Ownership Interests in Equity (Detail) (USD $)	3 Months Ended		12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Equity [Abstract]
Net income (loss) attributable to Health Insurance Innovations, Inc.	$53	($74)
Distributions	-319	-5	-264
Total	($266)	($79)

Stockbased_Compensation_Additi

Stock-based Compensation - Additional Information (Detail) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock - based compensation cost, capitalized	$0	$0
Forfeitures share during the period		0
Cash outflows resulting from settlement of stock based incentive plans	35,000	117,000
Income tax benefits from stock-based activity	$54,000	$47,000
Stock Appreciation Rights (SAR)
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Forfeitures of unvested stock appreciation rights share during the period	175,000
Stock appreciation rights shares exercises during the period	0	0
Restricted shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Forfeitures of unvested restricted shares during the period	150,000
Long Term Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock reserved for issuance	1,250,000
Long Term Incentive Plan , Expiration Period	10 years

Stockbased_Compensation_Summar

Stock-based Compensation - Summary of Weighted Average Assumptions (Detail)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Risk-free interest rate	1.60%	1.20%
Expected life	4 years 10 months 24 days	4 years 8 months 12 days
Expected volatility	40.70%	44.00%
Expected dividend yield	0.00%	0.00%

Stockbased_Compensation_Summar1

Stock-based Compensation - Summary of Restricted Shares, SARs, and Stock Options Granted (Detail) (Restricted shares)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015
Restricted shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Other than option granted	10

Stockbased_Compensation_Summar2

Stock-based Compensation - Summary of Stock-based Compensation Expenses (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense	$61	$405
Stock Appreciation Rights (SAR)
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense	-4	203
Restricted shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense	-66	202
Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense	$131

Stockbased_Compensation_Summar3

Stock-based Compensation - Summary of Unrecognized Stock-based Compensation (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unrecognized stock-based compensation amount	$1,676
Stock Appreciation Rights (SAR)
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unrecognized stock-based compensation amount	650
Stock-based compensation expense amount expected to be recognized	2 years 1 month 6 days
Restricted shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unrecognized stock-based compensation amount	688
Stock-based compensation expense amount expected to be recognized	1 year 10 months 24 days
Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unrecognized stock-based compensation amount	$338
Stock-based compensation expense amount expected to be recognized	1 year 3 months 18 days

Net_Income_Loss_per_Share_Comp

Net Income (Loss) per Share - Computations of Basic and Diluted Net Income (Loss) Per Share (Detail) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Earnings Loss Per Share [Line Items]
Basic net income (loss) attributable to Health Insurance Innovations, Inc.	$53	($74)
Average sharesbbasic	7,515,053	5,025,669
Effect of dilutive securities:
Average sharesbdiluted	7,714,339	5,025,669
Basic net income (loss) per share attributable to Health Insurance Innovations, Inc.	$0.01	($0.01)
Diluted net income (loss) per share attributable to Health Insurance Innovations, Inc.	$0.01	($0.01)
Restricted shares
Effect of dilutive securities:
Dilutive securities	181,928	0
Stock Options
Effect of dilutive securities:
Dilutive securities	17,358	0

Net_Income_Loss_per_Share_Addi

Net Income (Loss) per Share - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Restricted shares
Earnings Loss Per Share [Line Items]
Dilutive securities	181,928	0
Stock Appreciation Rights (SAR)
Earnings Loss Per Share [Line Items]
Dilutive securities		0
Stock Options
Earnings Loss Per Share [Line Items]
Dilutive securities	17,358	0

Net_Income_Loss_per_Share_Secu

Net Income (Loss) per Share - Securities Not Included in Diluted Net Income (Loss) per Share (Detail)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Restricted shares
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive securities	14	130
Stock Appreciation Rights (SAR)
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive securities	419	359
Stock Options
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive securities	23

Income_Taxes_Additional_Inform

Income Taxes - Additional Information (Detail) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income Tax Disclosure [Abstract]
Effective tax rate	-414.20%	11.40%
Benefit for income taxes	($336,000)	($32,000)
Change in gross unrecognized tax benefit	$0	$0

Commitments_and_Contingencies_

Commitments and Contingencies - Additional Information (Detail) (USD $)	3 Months Ended	0 Months Ended	1 Months Ended	0 Months Ended		12 Months Ended	3 Months Ended
	Mar. 31, 2015	Sep. 30, 2014	Jan. 31, 2015	Feb. 13, 2013	Dec. 15, 2014	Dec. 31, 2014	Mar. 31, 2014
			Note
Commitment And Contingencies [Line Items]
Exclusive option agreement maturity term	5 years
Total tax receivable agreement liability	$10,800,000
Advanced commissions	8,022,000					5,973,000
Payable by the Distributor			0
January 2015 MDF Note | Other current assets
Commitment And Contingencies [Line Items]
Advanced commissions	1,600,000
January 2015 MDF Note | Other long-term assets
Commitment And Contingencies [Line Items]
Advanced commissions	875,000
Distributor Promissory Note
Commitment And Contingencies [Line Items]
Variable secured promissory note , advance amount		4,800,000
Advanced commissions		1,500,000
Installment payment date description	The latter two installments will be made on the earlier of June 26, 2015 and February 26, 2016, respectively, or the achievement of certain levels of sales of our products, as defined in the September 2014 Note, on or before such dates.
Note maturity date		26-Apr-17
Number of additional variable secured promissory notes			2
Distributor Promissory Note | January 2015 Production Note
Commitment And Contingencies [Line Items]
Note maturity date			31-Dec-17
Distributor Promissory Note | January 2015 MDF Note
Commitment And Contingencies [Line Items]
Note maturity date			31-Dec-17
Distributor Promissory Note | January 2015 Revolver
Commitment And Contingencies [Line Items]
Date revolving promissory note to be increased			1-Jul-15
Annual interest rate			6.00%
Repayment of loan	Pursuant to the January 2015 Revolver, on each of December 31, 2015 and 2016, the Distributor shall make a payment to us in an amount that will reduce the amount outstanding under the January 2015 Revolver to $300,000 or less plus accrued interest on the principal amounts so repaid.
Maximum loan outstanding to revolver			300,000
Date of maturity			31-Dec-17
Loaned amount during the period			1,000,000
Accrued interest on notes receivable			13,000
Distributor Promissory Note | Second Installment
Commitment And Contingencies [Line Items]
Contingent note installment payment		1,500,000
Distributor Promissory Note | Second Installment | January 2015 Production Note
Commitment And Contingencies [Line Items]
Promissory note, maximum amount of loans and advances to be provided			500,000
Date of installment			1-Jul-15
Distributor Promissory Note | Second Installment | January 2015 MDF Note
Commitment And Contingencies [Line Items]
Promissory note, maximum amount of loans and advances to be provided			500,000
Date of installment			1-Jul-15
Distributor Promissory Note | Second Installment | January 2015 Revolver
Commitment And Contingencies [Line Items]
Date of installment			31-Dec-16
Distributor Promissory Note | Third Installment
Commitment And Contingencies [Line Items]
Contingent note installment payment		1,800,000
Distributor Promissory Note | Third Installment | January 2015 MDF Note
Commitment And Contingencies [Line Items]
Promissory note, maximum amount of loans and advances to be provided			500,000
Date of installment			1-Jan-16
Distributor Promissory Note | First Installment | January 2015 Production Note
Commitment And Contingencies [Line Items]
Amount already advanced to distributor under promissory note agreement			1,500,000
Distributor Promissory Note | First Installment | January 2015 MDF Note
Commitment And Contingencies [Line Items]
Amount already advanced to distributor under promissory note agreement			1,000,000
Distributor Promissory Note | First Installment | January 2015 Revolver
Commitment And Contingencies [Line Items]
Date of installment			31-Dec-15
Tax Receivable Agreement
Commitment And Contingencies [Line Items]
Tax receivable agreement liability	741,000
Amount paid under agreement	0
Series B Membership Interests
Commitment And Contingencies [Line Items]
Tax benefit payment, percentage				85.00%
Tax benefit saving, percentage				15.00%
Revolving Credit Facility
Commitment And Contingencies [Line Items]
Line of credit facility, term					3 years
Borrowing capacity					15,000,000
Debt instrument description of variable rate	30-day LIBOR
Amount drawn on RLOC	0					0
Description of covenants under the Facility	The RLOC is subject to customary covenants and restrictions which, among other things, require us to maintain minimum working capital equal to 1.50 times the outstanding balance, and require that our maximum funded debt to tangible net worth ratio shall not exceed 1.50 at any time during the term of the RLOC. The RLOC also imposes certain nonfinancial covenants on us that would require immediate payment if we, among other things, reorganize, merge, consolidate, or otherwise change ownership or business structure without the bankbs prior written consent.
Deferred financing costs capitalized	23,000
Revolving Credit Facility | London Interbank Offered Rate (LIBOR)
Commitment And Contingencies [Line Items]
Debt instrument basis spread on variable rate					1.95%
Exclusive Option Agreement
Commitment And Contingencies [Line Items]
Monthly payment for services agreement for the technology	16,000
Vendor Contracts
Commitment And Contingencies [Line Items]
Term of service agreement unless notice given	1 year
Required notice period to terminate service agreement	60 days
Vendor Contracts | Software Assignment Agreement
Commitment And Contingencies [Line Items]
System purchase amount	45,000
Vendor Contracts | Master Service Agreements
Commitment And Contingencies [Line Items]
Monthly payment for services agreement for the technology	26,000
Service agreement term	5 years
Agreement renewal	one-year terms unless we give 60 daysb
Maximum | Distributor Promissory Note | January 2015 Production Note
Commitment And Contingencies [Line Items]
Promissory note, maximum amount of loans and advances to be provided			2,000,000
Maximum | Distributor Promissory Note | January 2015 MDF Note
Commitment And Contingencies [Line Items]
Promissory note, maximum amount of loans and advances to be provided			2,000,000
Maximum | Distributor Promissory Note | January 2015 Revolver
Commitment And Contingencies [Line Items]
Promissory note, maximum amount of loans and advances to be provided			1,000,000
Maximum | Distributor Promissory Note | After July 1, 2015 | January 2015 Revolver
Commitment And Contingencies [Line Items]
Promissory note, maximum amount of loans and advances to be provided			1,500,000
Operating Lease Agreements
Commitment And Contingencies [Line Items]
Difference between cash rent payments and straight-line rent expense	83,000					60,000
Operating Lease Agreements | Health Plan Intermediaries Holdings, LLC | Minimum
Commitment And Contingencies [Line Items]
Lease agreement expires	2015
Operating Lease Agreements | Health Plan Intermediaries Holdings, LLC | Maximum
Commitment And Contingencies [Line Items]
Lease agreement expires	2019
Operating Lease Agreements | S, General & A Expenses
Commitment And Contingencies [Line Items]
Operating lease rental expense	$171,000						$73,000
Shares Issued Under Exchange Agreement | Common Stock Issuance Over Allotment Option | Class A common stock
Commitment And Contingencies [Line Items]
Issuance of common stock, shares	1,825,000

Fair_Value_Measurements_Summar

Fair Value Measurements - Summary of Assets and Liabilities Measured at Fair Value (Detail) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Carrying Value
Assets
Certificates of deposit		$461
Liabilities:
Noncompete obligation	421	463
Contingent acquisition consideration	3,459	4,400
Liabilities	3,880	4,863
Estimate of Fair Value Measurement | Fair Value Measurement Level 1
Assets
Certificates of deposit		461
Estimate of Fair Value Measurement | Fair Value Measurement Level 2
Liabilities:
Noncompete obligation	418	457
Liabilities	418	457
Estimate of Fair Value Measurement | Fair Value Measurement Level 3
Liabilities:
Contingent acquisition consideration	3,459	4,400
Liabilities	$3,459	$4,400

Fair_Value_Measurements_Summar1

Fair Value Measurements - Summary of the Changes in the Fair Value of Liabilities Carried at Fair Value (Detail) (Fair Value Measurement Level 3, Contingent Acquisition Consideration, USD $)	3 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Fair Value Measurement Level 3 | Contingent Acquisition Consideration
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Beginning Balance	$4,400	$3,876
Issuance and settlements, net	-450	-579
(Gain) Loss included in income	-491	1,103
Ending Balance	$3,459	$4,400

Segments_Additional_Informatio

Segments - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
	Segment	Segment
Segment Reporting [Abstract]
Number of reportable segments	2	1

Segments_Schedule_of_Financial

Segments - Schedule of Financial Results of Reportable Segments (Detail) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Segment Reporting Information [Line Items]
Revenue	$22,541,000	$17,927,000
Other operating expenses	22,483,000
Depreciation and amortization	784,000	405,000
Total operating expenses	23,267,000	17,560,000
Other income	-646,000
Net income (loss) before income taxes	-80,000	-280,000
Provision (benefit) for income taxes	-336,000	-32,000
Net income (loss)	256,000	-248,000	423,000
Total assets as of March 31, 2015	82,416,000		86,172,000
Operating Segments | Insurance Plan Development And Distribution
Segment Reporting Information [Line Items]
Revenue	22,112,000
Other operating expenses	21,413,000
Depreciation and amortization	464,000
Total operating expenses	21,877,000
Other income	-646,000
Net income (loss) before income taxes	881,000
Provision (benefit) for income taxes	54,000
Net income (loss)	827,000
Total assets as of March 31, 2015	53,198,000
Operating Segments | Health Pocket
Segment Reporting Information [Line Items]
Revenue	664,000
Other operating expenses	1,305,000
Depreciation and amortization	320,000
Total operating expenses	1,625,000
Net income (loss) before income taxes	-961,000
Provision (benefit) for income taxes	-390,000
Net income (loss)	-571,000
Total assets as of March 31, 2015	29,953,000
Intersegment Eliminations
Segment Reporting Information [Line Items]
Revenue	-235,000
Other operating expenses	-235,000
Total operating expenses	-235,000
Total assets as of March 31, 2015	($735,000)

Related_Party_Transactions_Add

Related Party Transactions - Additional Information (Detail) (USD $)	3 Months Ended		12 Months Ended	0 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Mar. 14, 2014	Mar. 23, 2015	Oct. 31, 2013
Related Party Transaction [Line Items]
Amount of distributions paid	$319,000	$5,000	$264,000
Other tax benefits recorded as liability, noncurrent	512,000		387,000
Total tax receivable agreement liability	10,800,000
Commissions payable	1,704,000		2,009,000
Health Plan Intermediaries Holdings, LLC
Related Party Transaction [Line Items]
Amount of distributions paid	319,000	921,000
Tax Receivable Agreement
Related Party Transaction [Line Items]
Amount paid under agreement	0
Tax receivable agreement liability	741,000		616,000
Other tax benefits recorded as liability, current	229,000		229,000
Other tax benefits recorded as liability, noncurrent	512,000		387,000
Health Benefits One L L C
Related Party Transaction [Line Items]
Advanced commissions payments, net	1,100,000	454,000
Commission expense, recognized	3,000,000	867,000
Commissions payable		2,300,000			3,400,000
Health Benefits One L L C | Simple Insurance Leads LLC
Related Party Transaction [Line Items]
Ownership of membership interests						50.00%
TSG
Related Party Transaction [Line Items]
Contract termination				$5,500,000

Subsequent_Events_Additional_I

Subsequent Events - Additional Information (Detail) (Subsequent Events, USD $)	0 Months Ended
	7-May-15	Apr. 30, 2015	1-May-15
Subsequent Event [Line Items]
Contingent consideration payment period	14 months
Contingent Consideration Payment Payout	$973,000
May 2015 Note
Subsequent Event [Line Items]
Note maturity date		31-Jan-17
Advance One | May 2015 Note
Subsequent Event [Line Items]
Variable secured promissory note , advance amount			500,000
Advance Two | May 2015 Note
Subsequent Event [Line Items]
Variable secured promissory note , advance amount			$500,000